<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle3.dtd?><?SourceDTD.Version 3.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">EMBO Mol Med</journal-id><journal-id journal-id-type="iso-abbrev">EMBO Mol Med</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)1757-4684</journal-id><journal-id journal-id-type="publisher-id">EMMM</journal-id><journal-id journal-id-type="hwp">embomm</journal-id><journal-title-group><journal-title>EMBO Molecular Medicine</journal-title></journal-title-group><issn pub-type="ppub">1757-4676</issn><issn pub-type="epub">1757-4684</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5666312</article-id><article-id pub-id-type="doi">10.15252/emmm.201708123</article-id><article-id pub-id-type="publisher-id">EMMM201708123</article-id><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Profiling <styled-content style="fixed-case">MHC II</styled-content> immunopeptidome of blood&#8208;stage malaria reveals that <styled-content style="fixed-case">cDC</styled-content>1 control the functionality of parasite&#8208;specific <styled-content style="fixed-case">CD</styled-content>4 T cells</article-title><alt-title alt-title-type="left-running-head">Marion Draheim <italic>et&#160;al</italic></alt-title></title-group><contrib-group><contrib id="emmm201708123-cr-0001" contrib-type="author"><name><surname>Draheim</surname><given-names>Marion</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emmm201708123-cr-0002" contrib-type="author"><name><surname>Wlodarczyk</surname><given-names>Myriam F</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emmm201708123-cr-0003" contrib-type="author"><name><surname>Crozat</surname><given-names>Karine</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="emmm201708123-cr-0004" contrib-type="author"><name><surname>Saliou</surname><given-names>Jean&#8208;Michel</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="emmm201708123-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="emmm201708123-cr-0005" contrib-type="author"><name><surname>Alayi</surname><given-names>Tchilabalo Dilezitoko</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7291-531X</contrib-id><xref ref-type="aff" rid="emmm201708123-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="emmm201708123-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="emmm201708123-cr-0006" contrib-type="author"><name><surname>Tomavo</surname><given-names>Stanislas</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0003">
<sup>3</sup>
</xref><xref ref-type="aff" rid="emmm201708123-aff-0004">
<sup>4</sup>
</xref></contrib><contrib id="emmm201708123-cr-0007" contrib-type="author"><name><surname>Hassan</surname><given-names>Ali</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emmm201708123-cr-0008" contrib-type="author"><name><surname>Salvioni</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emmm201708123-cr-0009" contrib-type="author"><name><surname>Demarta&#8208;Gatsi</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0005">
<sup>5</sup>
</xref></contrib><contrib id="emmm201708123-cr-0010" contrib-type="author"><name><surname>Sidney</surname><given-names>John</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="emmm201708123-cr-0011" contrib-type="author"><name><surname>Sette</surname><given-names>Alessandro</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0006">
<sup>6</sup>
</xref></contrib><contrib id="emmm201708123-cr-0012" contrib-type="author"><name><surname>Dalod</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="emmm201708123-cr-0013" contrib-type="author"><name><surname>Berry</surname><given-names>Antoine</given-names></name><xref ref-type="aff" rid="emmm201708123-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="emmm201708123-cr-0014" contrib-type="author"><name><surname>Silvie</surname><given-names>Olivier</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0525-6940</contrib-id><xref ref-type="aff" rid="emmm201708123-aff-0007">
<sup>7</sup>
</xref></contrib><contrib id="emmm201708123-cr-0015" contrib-type="author" corresp="yes"><name><surname>Blanchard</surname><given-names>Nicolas</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4924-2161</contrib-id><address><email>nicolas.blanchard@inserm.fr</email></address><xref ref-type="aff" rid="emmm201708123-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="emmm201708123-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Centre de Physiopathologie Toulouse Purpan (CPTP), INSERM, CNRS</named-content>
<institution>Universit&#233; de Toulouse, UPS</institution>
<named-content content-type="city">Toulouse</named-content>
<country country="FR">France</country>
</aff><aff id="emmm201708123-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">CNRS, INSERM, CIML</named-content>
<institution>Aix Marseille Universit&#233;</institution>
<named-content content-type="city">Marseille</named-content>
<country country="FR">France</country>
</aff><aff id="emmm201708123-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Centre d'Infection et d'Immunit&#233; de Lille (CIIL)</named-content>
<named-content content-type="organisation-division">CNRS UMR 8204, Inserm U1019, CHU Lille</named-content>
<named-content content-type="organisation-division">Institut Pasteur de Lille</named-content>
<institution>University of Lille</institution>
<named-content content-type="city">Lille</named-content>
<country country="FR">France</country>
</aff><aff id="emmm201708123-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Plateforme de Prot&#233;omique et Peptides Modifi&#233;s (P3M)</named-content>
<named-content content-type="organisation-division">CNRS, Institut Pasteur de Lille</named-content>
<institution>University of Lille</institution>
<named-content content-type="city">Lille</named-content>
<country country="FR">France</country>
</aff><aff id="emmm201708123-aff-0005">
<label><sup>5</sup></label>
<named-content content-type="organisation-division">CNRS, INSERM</named-content>
<named-content content-type="organisation-division">Institut Pasteur</named-content>
<institution>Unit&#233; de Biologie des Interactions H&#244;te Parasites</institution>
<named-content content-type="city">Paris</named-content>
<country country="FR">France</country>
</aff><aff id="emmm201708123-aff-0006">
<label><sup>6</sup></label>
<institution>La Jolla Institute of Allergy and Immunology</institution>
<named-content content-type="city">San Diego</named-content>
<named-content content-type="country-part">CA</named-content>
<country country="US">USA</country>
</aff><aff id="emmm201708123-aff-0007">
<label><sup>7</sup></label>
<named-content content-type="organisation-division">INSERM, CNRS</named-content>
<named-content content-type="organisation-division">Centre d'Immunologie et des Maladies Infectieuses</named-content>
<named-content content-type="organisation-division">Sorbonne Universit&#233;s</named-content>
<institution>UPMC University of Paris 06</institution>
<named-content content-type="city">Paris</named-content>
<country country="FR">France</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label>Corresponding author. Tel: +33 562 74 83 07; E&#8208;mail: <email>nicolas.blanchard@inserm.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>9</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>11</month><year>2017</year></pub-date><volume>9</volume><issue>11</issue><issue-id pub-id-type="doi">10.1002/emmm.v9.11</issue-id><fpage>1605</fpage><lpage>1621</lpage><history><date date-type="received"><day>08</day><month>6</month><year>2017</year></date><date date-type="rev-recd"><day>25</day><month>8</month><year>2017</year></date><date date-type="accepted"><day>29</day><month>8</month><year>2017</year></date></history><permissions><!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2017 EMBO <copyright-statement>--><copyright-statement content-type="article-copyright">&#169; 2017 The Authors. Published under the terms of the CC BY 4.0 license</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:EMMM-9-1605.pdf"/><abstract id="emmm201708123-abs-0001"><title>Abstract</title><p>In malaria, <styled-content style="fixed-case">CD</styled-content>4 Th1 and T follicular helper (<styled-content style="fixed-case">T<sub>FH</sub></styled-content>) cells are important for controlling parasite growth, but Th1 cells also contribute to immunopathology. Moreover, various regulatory <styled-content style="fixed-case">CD</styled-content>4 T&#8208;cell subsets are critical to hamper pathology. Yet the antigen&#8208;presenting cells controlling Th functionality, as well as the antigens recognized by <styled-content style="fixed-case">CD</styled-content>4 T cells, are largely unknown. Here, we characterize the <styled-content style="fixed-case">MHC II</styled-content> immunopeptidome presented by <styled-content style="fixed-case">DC</styled-content> during blood&#8208;stage malaria in mice. We establish the immunodominance hierarchy of 14 <styled-content style="fixed-case">MHC II</styled-content> ligands derived from conserved parasite proteins. Immunodominance is shaped differently whether blood stage is preceded or not by liver stage, but the same <styled-content style="fixed-case">ETRAMP</styled-content>&#8208;specific dominant response develops in both contexts. In na&#239;ve mice and at the onset of cerebral malaria, <styled-content style="fixed-case">CD</styled-content>8&#945;<sup>+</sup> dendritic cells (<styled-content style="fixed-case">cDC</styled-content>1) are superior to other <styled-content style="fixed-case">DC</styled-content> subsets for <styled-content style="fixed-case">MHC II</styled-content> presentation of the <styled-content style="fixed-case">ETRAMP</styled-content> epitope. Using <italic>in&#160;vivo</italic> depletion of <styled-content style="fixed-case">cDC</styled-content>1, we show that <styled-content style="fixed-case">cDC</styled-content>1 promote parasite&#8208;specific Th1 cells and inhibit the development of <styled-content style="fixed-case">IL</styled-content>&#8208;10<sup>+</sup>
<styled-content style="fixed-case">CD</styled-content>4 T cells. This work profiles the <italic>P.&#160;berghei</italic> blood&#8208;stage <styled-content style="fixed-case">MHC II</styled-content> immunopeptidome, highlights the potency of <styled-content style="fixed-case">cDC</styled-content>1 to present malaria antigens on <styled-content style="fixed-case">MHC II</styled-content>, and reveals a major role for <styled-content style="fixed-case">cDC</styled-content>1 in regulating malaria&#8208;specific <styled-content style="fixed-case">CD</styled-content>4 T&#8208;cell responses.</p></abstract><kwd-group kwd-group-type="author-generated"><kwd id="emmm201708123-kwd-0001">CD4 T cell</kwd><kwd id="emmm201708123-kwd-0002">dendritic cell</kwd><kwd id="emmm201708123-kwd-0003">malaria</kwd><kwd id="emmm201708123-kwd-0004">MHC II presentation</kwd><kwd id="emmm201708123-kwd-0005"><italic>Plasmodium berghei</italic></kwd></kwd-group><kwd-group kwd-group-type="subject-categories"><title>Subject Categories</title><kwd>Immunology</kwd><kwd>Microbiology, Virology &amp; Host Pathogen Interaction</kwd></kwd-group><funding-group><award-group><funding-source>R&#233;gion Occitanie PhD co&#8208;funding</funding-source></award-group><award-group><funding-source>Minist&#232;re de l'Education Nationale, de la Recherche et de la Technologie</funding-source></award-group><award-group><funding-source>Idex Toulouse &#8220;Attractivity Chair&#8221; Program</funding-source></award-group><award-group><funding-source>Human Frontier Science Program (HFSP)</funding-source><award-id>CDA00047/2011</award-id></award-group><award-group><funding-source>Agence Nationale de la Recherche (ANR)</funding-source><award-id>ANR&#8208;11&#8208;LABX0024</award-id><award-id>ANR&#8208;11&#8208;EQPX&#8208;0003</award-id></award-group></funding-group><counts><fig-count count="9"/><table-count count="1"/><page-count count="17"/><word-count count="13621"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>emmm201708123</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>November 2017</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.2.1 mode:remove_FC converted:02.11.2017</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="emmm201708123-cit-1001">
<source>EMBO Mol Med</source> (<year>2017</year>) <volume>9</volume>: <fpage>1605</fpage>&#8211;<lpage>1621</lpage>
</mixed-citation>
</p></notes></front><body><sec id="emmm201708123-sec-0001"><title>Introduction</title><p>Malaria is caused by parasites of the <italic>Plasmodium</italic> genus. This disease continues to threaten nearly half of the world's population and to kill more than 400,000 people yearly. Malaria infection leads to a broad spectrum of diseases with varying severity. While some asymptomatic parasite carriers show no clinical signs, individuals with uncomplicated malaria present mild symptoms, like fever and/or myalgia, and severe malaria patients face deadly manifestations, such as anemia or cerebral malaria. The diversity of human malaria pathophysiology can be recapitulated in part using different combinations of mouse backgrounds and rodent&#8208;adapted <italic>Plasmodium</italic> species. Altogether, rodent studies have revealed the complex and dual roles of T cells, which seem to be involved both in protection and in pathogenesis (Freitas do Rosario &amp; Langhorne, <xref rid="emmm201708123-bib-0026" ref-type="ref">2012</xref>; Howland <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0039" ref-type="ref">2015a</xref>).</p><p>CD8 T cells are essential to contain parasite development during the initial liver stages (Frevert &amp; Krzych, <xref rid="emmm201708123-bib-0027" ref-type="ref">2015</xref>; Radtke <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0067" ref-type="ref">2015b</xref>). During blood stage, when parasites reside exclusively within erythrocytes, CD8 T cells may target MHC I&#8208;positive parasitized erythroblasts (Imai <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0041" ref-type="ref">2013</xref>) and be involved in parasite clearance (Safeukui <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0070" ref-type="ref">2015</xref>). Besides these protective functions, CD8 T cells play a well&#8208;established deleterious role in the vascular pathology associated with experimental cerebral malaria (ECM). A hallmark of ECM is the cross&#8208;presentation of parasite antigens by endothelial cells of cerebral microcapillaries to CD8 T cells (Howland <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0040" ref-type="ref">2015b</xref>; Swanson <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0082" ref-type="ref">2016</xref>). Combined to a restriction in venous blood efflux due to cell sequestration (Nacer <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0054" ref-type="ref">2014</xref>), the CD8&#8208;mediated processes are considered pivotal in the vascular breakdown and fatal condition.</p><p>Being major producers of inflammatory and regulatory cytokines, CD4 T cells are critical fine&#8208;tuners of the balance between protection and pathology. On the one hand, CD4 T cells contribute to parasite control. Effector memory Th1 CD4 T cells confer partial protection in the self&#8208;resolutive <italic>Plasmodium chabaudi chabaudi</italic> (<italic>Pcc</italic>) model (Stephens &amp; Langhorne, <xref rid="emmm201708123-bib-0081" ref-type="ref">2010</xref>), and loss of T&#8208;bet, a master regulator of Th1 differentiation, impairs control of parasitemia in the <italic>Plasmodium berghei</italic> ANKA (<italic>Pb</italic>A) model (Oakley <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0056" ref-type="ref">2013</xref>). Moreover, a subset of CD4 T cells, called T follicular helper (T<sub>FH</sub>) cells, releases the B&#8208;cell&#8208;helping IL&#8208;21 cytokine (Perez&#8208;Mazliah <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0061" ref-type="ref">2015</xref>) and is key to promote effective germinal center formation and anti&#8208;parasite humoral immunity (Sebina <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0074" ref-type="ref">2016</xref>; Zander <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0091" ref-type="ref">2016</xref>).</p><p>On the other hand, CD4 T cells also contribute to malaria&#8208;associated pathology. By secreting IFN&#947; in the first days of infection (Belnoue <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0006" ref-type="ref">2002</xref>; Villegas&#8208;Mendez <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0087" ref-type="ref">2012</xref>), CD4 T cells promote CXCL9&#8208; and CXCL10&#8208;dependent CXCR3&#8208;mediated accumulation of CD8 T cells in the brain (Campanella <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0010" ref-type="ref">2008</xref>; Van den Steen <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0086" ref-type="ref">2008</xref>). Accordingly, T&#8208;bet&#8208;deficient (Oakley <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0056" ref-type="ref">2013</xref>) and IL&#8208;12Rbeta2&#8208;deficient (Fauconnier <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0023" ref-type="ref">2012</xref>) mice are less susceptible to ECM development. In addition, production of regulatory cytokines, such as IL&#8208;10 (Couper <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0016" ref-type="ref">2008</xref>; Freitas do Rosario <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0025" ref-type="ref">2012</xref>; Villegas&#8208;Mendez <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0088" ref-type="ref">2016</xref>; Claser <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0014" ref-type="ref">2017</xref>) and IL&#8208;27 (Kimura <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0044" ref-type="ref">2016</xref>), by CD4 T cells is instrumental for tilting the balance away from pathology. Yet despite the central role of CD4 T cells in regulating protective <italic>versus</italic> deleterious immunity during malaria, their cognate antigens, as well as the antigen&#8208;presenting cells (APC) controlling their differentiation, are poorly characterized.</p><p>Chief among these APC are the dendritic cells (DC). DC concomitantly act as innate sensors of pathogen motifs, activators of innate immune cells, and initiators of the adaptive T&#8208;cell&#8208;mediated immunity. DC comprise two major branches: the plasmacytoid DC (pDC) and the conventional DC (cDC), which, based on ontogeny, can be further subdivided into cDC1 and cDC2 (Guilliams <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0030" ref-type="ref">2014</xref>). Schematically, pDC are viewed as specialized to respond to viral infection by producing type I IFN, and cDC are considered as the most potent T&#8208;cell&#8208;activating cells (Durai &amp; Murphy, <xref rid="emmm201708123-bib-0020" ref-type="ref">2016</xref>), even though depending on the context, tissue, or species analyzed, these functions may be completely or partially shared.</p><p>Early evidence suggested a functional dichotomy in antigen presentation among cDC, with cDC1 being best&#8208;equipped for cross&#8208;priming CD8 T cells and cDC2 preferentially activating CD4 T cells. This specialization was proposed after specifically targeting the same antigen to each subset (Dudziak <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0019" ref-type="ref">2007</xref>). Since then, the specific requirement for cDC1 in cross&#8208;priming CD8 T cells has been confirmed in viral (Hildner <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0036" ref-type="ref">2008</xref>; Helft <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0034" ref-type="ref">2012</xref>), bacterial (Yamazaki <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0090" ref-type="ref">2013</xref>), and parasite (Mashayekhi <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0053" ref-type="ref">2011</xref>; Piva <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0062" ref-type="ref">2012</xref>; Lau <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0046" ref-type="ref">2014</xref>; Radtke <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0066" ref-type="ref">2015a</xref>) infections. Furthermore, cDC1 are instrumental to reactivate memory CD8 T cells in response to <italic>Listeria</italic> or virus assaults (Alexandre <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0001" ref-type="ref">2016</xref>). With respect to CD4 T&#8208;cell activation, the respective performances of cDC1 and cDC2 seem to vary according to the context and source of antigen. For yeast&#8208;associated antigens, cDC2 perform better than cDC1 (Backer <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0005" ref-type="ref">2008</xref>) while for cell&#8208;associated antigens, cDC1 are more potent than cDC2 (Schnorrer <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0072" ref-type="ref">2006</xref>). The bacterial antigen presentation capacity of cDC1 and cDC2 appears equivalent when incubated with fixed bacteria (Schnorrer <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0072" ref-type="ref">2006</xref>). <italic>In vivo</italic>, some studies showed only a limited role for cDC1 in priming CD4 T cells against a soluble antigen (Yamazaki <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0090" ref-type="ref">2013</xref>) or the West Nile Virus (Hildner <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0036" ref-type="ref">2008</xref>). In agreement, cDC2 but not cDC1 are necessary for proper T<sub>FH</sub> differentiation after immunization with allogeneic red blood cell (RBC) (Calabro <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0009" ref-type="ref">2016</xref>). In contrast, in other contexts such as during <italic>Leishmania major</italic> (Ashok <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0003" ref-type="ref">2014</xref>; Martinez&#8208;Lopez <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0052" ref-type="ref">2015</xref>) and <italic>Toxoplasma gondii</italic> (Mashayekhi <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0053" ref-type="ref">2011</xref>) parasite infections, cDC1 are critical to drive Th1 responses. Of note, it has been shown in the course of a viral infection that by interacting with pre&#8208;activated CD4 T cells, cDC1 constitute a platform for delivery of CD4 T cell help to CD8 T cells (Eickhoff <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0022" ref-type="ref">2015</xref>; Hor <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0037" ref-type="ref">2015</xref>).</p><p>In malaria, the respective contributions of DC subsets in controlling CD4 T&#8208;cell activation are ill&#8208;defined. In the self&#8208;resolutive <italic>Pcc</italic> model, cDC2 are more potent than cDC1 for MHC II presentation of two MSP1 epitopes until day 11 post&#8208;infection, but for reasons that were not elucidated, the trend is reversed a few days later (Sponaas <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0080" ref-type="ref">2006</xref>). In this model, a more recent study identified a role for inflammatory monocytes in promoting Th1 responses (Lonnberg <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0048" ref-type="ref">2017</xref>). During <italic>Pb</italic>A infection, MHC II presentation by splenic cDC1 at day 3 was found to be more efficient compared to cDC2 in one study (Lundie <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0050" ref-type="ref">2010</xref>) but roughly similar to cDC2 in another (Lundie <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0049" ref-type="ref">2008</xref>). Importantly, this was evaluated in BALB/c mice, which are more resistant to neuroinflammation than C57BL/6 (B6) mice (Hafalla <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0031" ref-type="ref">2012</xref>), and with a model antigen. In conclusion, the implication of DC subsets in controlling endogenous CD4 T&#8208;cell responses during severe malaria remains unsettled.</p><p>Here, we profiled the MHC II immunopeptidome presented by DC to CD4 T cells during <italic>Pb</italic> infection and we engineered reporter CD4 T&#8208;cell hybridomas specific for the most prominent ETRAMP10.2 epitope. We report that in na&#239;ve and malaria&#8208;infected mice, cDC1 are more potent than cDC2 for presenting <italic>Plasmodium</italic> antigens and that selective <italic>in&#160;vivo</italic> ablation of cDC1 blunts the development of parasite&#8208;specific Th1 responses.</p></sec><sec id="emmm201708123-sec-0002"><title>Results</title><sec id="emmm201708123-sec-0003"><title>Profiling the <italic>Plasmodium berghei</italic>&#8208;derived MHC II immunopeptidome</title><p>Characterizing MHC II ligands and creating parasite&#8208;specific reporter T cells are critical steps to understand the modalities of antigen presentation and CD4 T&#8208;cell polarization during blood&#8208;stage malaria.</p><p>We used mass spectrometry to globally characterize <italic>Pb</italic> antigenic peptides presented by MHC II on the surface of DC (Fig&#160;<xref rid="emmm201708123-fig-0001" ref-type="fig">1</xref>A). We immunoprecipitated the MHC II molecules from a splenic DC tumor cell line called MutuDC (Fuertes Marraco <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0028" ref-type="ref">2012</xref>), incubated with <italic>Pb</italic>&#8208;parasitized RBC (pRBC). Peptide&#8208;loaded MHC II are trimers of I&#8208;A<sup>b</sup>&#945; chain, I&#8208;A<sup>b</sup>&#946; chain, and antigenic peptide, which, depending on the affinity of the loaded peptide, can remain stable in SDS without prior boiling (Natarajan <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0055" ref-type="ref">1999</xref>). To ensure that our protocol allowed the pull&#8208;down of peptide&#8208;MHC II trimers and not just of single I&#8208;A<sup>b</sup>&#946; chain, we compared the migration of eluates with and without prior boiling, confirming that the immunoprecipitated material was SDS&#8208;stable (Fig&#160;<xref rid="emmm201708123-fig-0001" ref-type="fig">1</xref>B). Although genetically very close to <italic>Pb</italic>A (Otto <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0058" ref-type="ref">2014</xref>), several variants of <italic>Pb</italic> causing different pathophysiological outcomes have been described (de Souza <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0078" ref-type="ref">2010</xref>). <italic>Pb</italic> K173 (<italic>Pb</italic>K) being the most &#8220;distant&#8221; from <italic>Pb</italic>A (although SNPs were found only in 469 of &gt;&#160;15,000 genes; Otto <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0058" ref-type="ref">2014</xref>), we decided to perform this analysis both with <italic>Pb</italic>A and <italic>Pb</italic>K pRBC. This led to the identification of a total of 372 unique I&#8208;A<sup>b</sup>&#8208;eluted peptides, comprising 330 mouse sequences and 42 <italic>Pb</italic> sequences (Fig&#160;<xref rid="emmm201708123-fig-0001" ref-type="fig">1</xref>C, <xref rid="emmm201708123-sup-0002" ref-type="supplementary-material">Dataset EV1</xref>), derived from 13 putative <italic>Pb</italic> antigenic proteins (<xref rid="emmm201708123-sup-0003" ref-type="supplementary-material">Dataset EV2</xref>). In line with the modest level of polymorphisms between <italic>Pb</italic>A and <italic>Pb</italic>K, none of those source antigens was polymorphic. Remarkably, for seven antigens, we recovered multiple peptides containing a core of 11&#8211;16 amino acids (aa) and various N&#8208; or C&#8208;terminal extensions (<xref rid="emmm201708123-sup-0003" ref-type="supplementary-material">Dataset EV2</xref>). This feature is a typical property of MHC II ligands (Bozzacco <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0007" ref-type="ref">2011</xref>; Sofron <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0077" ref-type="ref">2016</xref>). For each set of nested peptides, we further analyzed the longest spanning sequence comprising all recovered sequences, for example, NALYNYSIPRPNVTSNL for ETRAMP10.2 (PBANKA_0517000) or LHASPYVAPAAAIIEMAE for LDH (PBANKA_1340100), resulting in a consolidated list of 14 peptides (Table&#160;<xref rid="emmm201708123-tbl-0001" ref-type="table-wrap">1</xref>). We evaluated the I&#8208;A<sup>b</sup> binding affinity of these 14 peptides by quantifying their ability to inhibit binding of a high&#8208;affinity radiolabeled peptide (Sidney <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0075" ref-type="ref">2013</xref>). Ten peptides were found to be good I&#8208;A<sup>b</sup> binders (IC<sub>50</sub>&#160;&lt;&#160;1,000&#160;nM), three moderate binders (IC<sub>50</sub>&#160;&lt;&#160;5,000&#160;nM), and one low binder (IC<sub>50</sub>&#160;&gt;&#160;5,000&#160;nM; Table&#160;<xref rid="emmm201708123-tbl-0001" ref-type="table-wrap">1</xref>).</p><fig fig-type="Figure" xml:lang="en" id="emmm201708123-fig-0001" orientation="portrait" position="float"><label>Figure 1</label><caption><title>
<styled-content style="fixed-case">MS</styled-content>/<styled-content style="fixed-case">MS</styled-content> profiling of <italic>Pb</italic>&#8208;derived <styled-content style="fixed-case">MHC II</styled-content> immunopeptidome during blood&#8208;stage malaria</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0002"><list-item><p>Experimental protocol used to immunoprecipitate MHC II molecules from <italic>Pb</italic>K or <italic>Pb</italic>A pRBC&#8208;loaded MutuDC and to elute MHC II&#8208;bound peptides before proteomic analysis.</p></list-item><list-item><p>Western blot revealed with anti&#8208;I&#8208;A<sup>b</sup>&#946; JV2 antibody. WCL: whole&#8208;cell lysate of MutuDC&#160;+&#160;pRBC; S0: supernatant following incubation with protein&#8208;G beads; S1: 1<sup>st</sup> wash of protein&#8208;G beads; IP MHC II: eluates from Y&#8208;3P&#8208;immunoprecipitated MHC II, boiled or not. Representative of two independent experiments.</p></list-item><list-item><p>Venn diagram of unique peptides from <italic>P.&#160;berghei</italic> (left) and <italic>Mus musculus</italic> (right) identified in the experiments performed with <italic>Pb</italic>K pRBC (blue) and <italic>Pb</italic>A pRBC (orange).</p></list-item></list>
</p></caption><graphic id="nlm-graphic-5" xlink:href="EMMM-9-1605-g002"/></fig><table-wrap id="emmm201708123-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>List of synthetic peptides tested in this study and their binding affinity to I&#8208;A<sup>b</sup>
</p></caption><table-wrap-foot><fn id="emmm201708123-note-0001"><p>In the last column, IC<sub>50</sub> values lower than 1,000&#160;nM (corresponding to good I&#8208;A<sup>b</sup> binders) are shown in bold.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder></permissions></table-wrap><p>In summary, our analysis of the I&#8208;A<sup>b</sup> immunopeptidome in DC identifies a panel of 14 MHC II ligands derived from 13 non&#8208;polymorphic antigenic proteins expressed by <italic>Pb</italic>A and <italic>Pb</italic>K.</p></sec><sec id="emmm201708123-sec-0004"><title>
<italic>In vivo</italic> relevance of the peptide panel during blood&#8208;stage malaria</title><p>In order to validate this panel <italic>in&#160;vivo</italic>, we measured the frequency of CD4 T cells responding to each peptide during <italic>Pb</italic>A pRBC infection (Fig&#160;<xref rid="emmm201708123-fig-0002" ref-type="fig">2</xref>A). Splenic T cells were restimulated with DC loaded with an irrelevant peptide (OVA) or uninfected RBC as negative controls, and with <italic>Pb</italic>A pRBC as positive control. The latter condition allowed estimating the abundance of total parasite&#8208;specific CD4 T cells in the spleen, regardless of their peptide specificity. We chose a 10:1 ratio of pRBC to DC (Fig&#160;<xref rid="emmm201708123-fig-0001ev" ref-type="fig">EV1</xref>A), and we focused on day 6 post&#8208;infection (corresponding to ECM onset) since the parasite&#8208;specific CD4 T&#8208;cell response was maximal at this time point and the mice succumbed beyond this day (Fig&#160;<xref rid="emmm201708123-fig-0001ev" ref-type="fig">EV1</xref>B and C). In accordance with earlier studies (Villegas&#8208;Mendez <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0087" ref-type="ref">2012</xref>), we observed a substantial &#8220;spontaneous&#8221; release of IFN&#947; by activated CD4 T cells (CD4<sup>+</sup> CD11a<sup>+</sup> CD49d<sup>+</sup>) regardless of <italic>ex&#160;vivo</italic> re&#8208;exposure to antigen (Fig&#160;<xref rid="emmm201708123-fig-0002" ref-type="fig">2</xref>B). In order to improve the specificity of detection of genuine parasite&#8208;specific CD4 T cells, we focused on double IFN&#947;/TNF&#8208;producing cells. Thirteen of 14 peptides elicited a higher IFN&#947;/TNF production than the OVA peptide, with eight showing statistical significance. The three most dominant peptides originated from ETRAMP10.2 (NALYNYSIPRPNVTSNL, NL17), GAPDH (GINHEKYNSSQTIVSNAS, GS18), and EF1&#945; (SGKVVEENPKAIKSGDS, SS17) proteins (Fig&#160;<xref rid="emmm201708123-fig-0002" ref-type="fig">2</xref>C). In total, CD4 T cells specific for those three peptides comprised more than one&#8208;third of the entire <italic>Pb</italic>A&#8208;specific response (Fig&#160;<xref rid="emmm201708123-fig-0002" ref-type="fig">2</xref>D). In line with the inability of <italic>Pb</italic>K pRBC to induce ECM at a 10<sup>6</sup> pRBC inoculum (data not shown), the proportion of IFN&#947;/TNF&#8208;producing CD4 T cells in <italic>Pb</italic>K&#8208;infected mice was lower. Yet the three most dominant responses were conserved overall (Fig&#160;<xref rid="emmm201708123-fig-0002ev" ref-type="fig">EV2</xref>A). This peptide panel was also relevant in two other malaria models, in which protection strongly relies on humoral responses. In the self&#8208;resolutive <italic>Pcc</italic> model, six of 10 peptides tested elicited IFN&#947;/TNF&#8208;producing CD4 responses at day 6 post&#8208;infection (Fig&#160;<xref rid="emmm201708123-fig-0002ev" ref-type="fig">EV2</xref>B). Note that the identified ETRAMP and MSP1 peptides are not expressed by&#160;<italic>Pcc</italic> due to sequence polymorphisms, hence the absence of reactivity. Another model of interest is the genetically attenuated parasite (GAP) <italic>P.&#160;berghei</italic> NK65 which lacks the histamine&#8208;releasing factor (<italic>Pb</italic> NK65 &#916;HRF). This vaccine strain, in which the sequences of all identified peptides are conserved (Otto <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0058" ref-type="ref">2014</xref>), causes self&#8208;resolving blood&#8208;stage infection and results in long&#8208;lasting cross&#8208;stage and cross&#8208;species immunity (Demarta&#8208;Gatsi <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0018" ref-type="ref">2016</xref>).&#160;Three weeks post&#8208;challenge with <italic>Pb</italic> NK65 &#916;HRF, we could detect CD4 T cells reactive against 11 of the identified peptides (Fig&#160;<xref rid="emmm201708123-fig-0002ev" ref-type="fig">EV2</xref>C).</p><fig fig-type="Figure" xml:lang="en" id="emmm201708123-fig-0002" orientation="portrait" position="float"><label>Figure 2</label><caption><title>Immunodominance of <italic>Pb</italic>A&#8208;derived <styled-content style="fixed-case">MHC II</styled-content> peptides during blood&#8208;stage malaria induced after <styled-content style="fixed-case">pRBC</styled-content> infection</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0003"><list-item><p>Experimental scheme to analyze splenic CD4 T&#8208;cell responses at day 6 following inoculation of <italic>Pb</italic>A pRBC.</p></list-item><list-item><p>Gating strategy to calculate the proportion of CD11a<sup>+</sup> CD49d<sup>+</sup>&#8208;activated CD4 T cells that produce IFN&#947; and TNF in response to MutuDC loaded with RBC, <italic>Pb</italic>A pRBC, OVA peptide (IR17), or ETRAMP10.2 peptide (NL17).</p></list-item><list-item><p>Percentage of IFN&#947;/TNF&#8208;double&#8208;producing cells among activated CD4 T cells for each peptide. Basal level with MutuDC alone was subtracted.</p></list-item><list-item><p>Hierarchy of immunodominance, depicted as the percentage of each peptide&#8208;specific response with respect to the total parasite&#8208;specific response obtained with <italic>Pb</italic>A pRBC&#8208;loaded MutuDC.</p></list-item></list>Data information: In (C, D), data show the mean&#160;&#177;&#160;SEM. Asterisks show statistical significance assessed by paired nonparametric Wilcoxon tests in comparison with OVA peptide. Panel (C): AMA1, *<italic>P</italic>&#160;=&#160;0.0098; TIM14, <italic>P</italic>&#160;=&#160;0.078; ENO, *<italic>P</italic>&#160;=&#160;0.016; GAPDH.1, *<italic>P</italic>&#160;=&#160;0.002; MAHRP, *<italic>P</italic>&#160;=&#160;0.0039; EF1&#945;, *<italic>P</italic>&#160;=&#160;0.0039; M1, *<italic>P</italic>&#160;=&#160;0.016; MSP1, *<italic>P</italic>&#160;=&#160;0.031; LDH, <italic>P</italic>&#160;=&#160;0.062; ETRAMP, *<italic>P</italic>&#160;=&#160;0.001; ATPSYN, <italic>P</italic>&#160;=&#160;0.25; END70, <italic>P</italic>&#160;=&#160;0.25; PDI, <italic>P</italic>&#160;=&#160;0.16; GAPDH.2, <italic>P</italic>&#160;=&#160;0.99; pRBC, *<italic>P</italic>&#160;=&#160;0.001. Panel (D): AMA1, *<italic>P</italic>&#160;=&#160;0.0098; TIM14, <italic>P</italic>&#160;=&#160;0.16; ENO, *<italic>P</italic>&#160;=&#160;0.016; GAPDH.1, *<italic>P</italic>&#160;=&#160;0.002; MAHRP, *<italic>P</italic>&#160;=&#160;0.0039; EF1a, *<italic>P</italic>&#160;=&#160;0.0039; M1, *<italic>P</italic>&#160;=&#160;0.016; MSP1, *<italic>P</italic>&#160;=&#160;0.031; LDH, <italic>P</italic>&#160;=&#160;0.062; ETRAMP, *<italic>P</italic>&#160;=&#160;0.001; ATPSYN, <italic>P</italic>&#160;=&#160;0.25; END70, <italic>P</italic>&#160;=&#160;0.25; PDI, <italic>P</italic>&#160;=&#160;0.16; GAPDH.2, <italic>P</italic>&#160;=&#160;0.99. <italic>N</italic>&#160;=&#160;6 mice for ATPSYN, END70, PDI, GAPDH.2, <italic>N</italic>&#160;=&#160;11 mice for all other peptides, pooled from three replicates.</p></caption><graphic id="nlm-graphic-7" xlink:href="EMMM-9-1605-g004"/></fig><fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="emmm201708123-fig-0001ev" orientation="portrait" position="float"><label>Figure EV1</label><caption><title>
<italic>Pb</italic>A&#8208;specific <styled-content style="fixed-case">CD</styled-content>4 T&#8208;cell responses are maximal at day 6 post&#8208;<styled-content style="fixed-case">pRBC</styled-content> infection</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0007"><list-item><p>Proportion of CD11a<sup>+</sup> CD49d<sup>+</sup> CD4 T cells (mean&#160;&#177;&#160;SEM) that produce IFN&#947; and TNF in response to MutuDC loaded with increasing ratio of <italic>Pb</italic>A pRBC, analyzed at day 6 post&#8208;infection with <italic>Pb</italic>A pRBC. <italic>N</italic>&#160;=&#160;3 mice.</p></list-item><list-item><p>Proportion of CD11a<sup>+</sup> CD49d<sup>+</sup> CD4 T cells (mean&#160;&#177;&#160;SEM) that produce IFN&#947; and TNF in response to MutuDC loaded with <italic>Pb</italic>A pRBC (ratio 10:1, black bars) or uninfected RBC (white bars), after infection with <italic>Pb</italic>A pRBC. <italic>N</italic>&#160;=&#160;4 mice per group. Asterisks show significant differences. Day 4, <italic>P</italic>&#160;=&#160;0.024; Day 5, *<italic>P</italic>&#160;=&#160;0.003; Day 6, *<italic>P</italic>&#160;=&#160;2.5&#160;&#215;&#160;10<sup>&#8722;5</sup> by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD.</p></list-item><list-item><p>Blood parasitemia (mean&#160;&#177;&#160;SEM) during infection with <italic>Pb</italic>A pRBC (black circles, <italic>N</italic>&#160;=&#160;5 mice) or <italic>Pb</italic>A.GFP spz (gray squares, <italic>N</italic>&#160;=&#160;15 mice). Asterisks show significant differences between the two groups. Day 4, <italic>P</italic>&#160;=&#160;0.14; Day 6, *<italic>P</italic>&#160;=&#160;0.011; Day 7, *<italic>P</italic>&#160;=&#160;0.0007 by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-9" xlink:href="EMMM-9-1605-g003"/></fig><fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="emmm201708123-fig-0002ev" orientation="portrait" position="float"><label>Figure EV2</label><caption><title>Peptide&#8208;specific <styled-content style="fixed-case">CD</styled-content>4 responses after challenge with <italic>Pb</italic>K, <italic>Pcc,</italic> or <italic>Pb</italic>
<styled-content style="fixed-case">NK</styled-content>65 &#916;<styled-content style="fixed-case">HRF</styled-content>
</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0008"><list-item><p>IFN&#947;/TNF&#8208;double&#8208;producing cells among activated CD4 T cells at day 6 post&#8208;infection with <italic>Pb</italic>K (mean&#160;&#177;&#160;SEM). <italic>N</italic>&#160;=&#160;6 mice. Basal level with MutuDC alone was subtracted. Asterisks show statistical significance assessed by paired nonparametric Wilcoxon tests in comparison with OVA peptide. GAPDH.1, *<italic>P</italic>&#160;=&#160;0.031; <italic>Pb</italic>K pRBC, *<italic>P</italic>&#160;=&#160;0.031. Responses to ATPSYN, END70, PDI, and GAPDH.2 were not determined (nd). Experiments performed once.</p></list-item><list-item><p>IFN&#947;/TNF&#8208;double&#8208;producing cells among activated CD4 T cells at day 6 post&#8208;infection with <italic>Pcc</italic> (mean&#160;&#177;&#160;SEM). <italic>N</italic>&#160;=&#160;4 mice. Basal level with MutuDC alone was subtracted. Responses to ATPSYN, END70, PDI, and GAPDH.2 were not determined (nd). Experiments performed once.</p></list-item><list-item><p>IFN&#947;/TNF&#8208;double&#8208;producing cells among CD4 T cells at day 21 post&#8208;challenge with genetically attenuated <italic>Pb</italic> NK65 &#916;HRF (mean&#160;&#177;&#160;SEM). <italic>N</italic>&#160;=&#160;4 mice. Basal level with MutuDC alone was subtracted. Dotted line indicates the response to OVA peptide. Experiments performed once.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-11" xlink:href="EMMM-9-1605-g005"/></fig><p>While injection of pRBC is a widely used model to induce blood&#8208;stage malaria, natural infection normally starts with the inoculation of mosquito&#8208;derived sporozoites (spz) followed by pre&#8208;erythrocytic stages. To investigate the relevance of the peptide panel in blood&#8208;stage responses developing after pre&#8208;erythrocytic stages, we infected mice with <italic>Pb</italic>A spz. Since liver stages last ~48&#160;h in rodents, we analyzed the CD4 responses at day 8 pi (Fig&#160;<xref rid="emmm201708123-fig-0003" ref-type="fig">3</xref>A), which is also the time of ECM onset in this model (Fig&#160;<xref rid="emmm201708123-fig-0001ev" ref-type="fig">EV1</xref>C). We first noticed that the amplitude of the total parasite&#8208;specific CD4 response (as indicated by the pRBC&#8208;loaded DC condition, Fig&#160;<xref rid="emmm201708123-fig-0003" ref-type="fig">3</xref>B) was ~fourfold lower than at day 6 post&#8208;infection with pRBC (see Fig&#160;<xref rid="emmm201708123-fig-0002" ref-type="fig">2</xref>C). Furthermore, the immunodominance hierarchy slightly differed and this time, the immunodominant response was targeted to the GS18 peptide from GAPDH (Fig&#160;<xref rid="emmm201708123-fig-0003" ref-type="fig">3</xref>B), which was the 2<sup>nd</sup> dominant peptide after pRBC challenge. Immunodominance can be driven by different parameters, but antigen abundance usually plays a major role. Given that RNA&#8208;seq analysis at blood stage showed a similar and relatively high mRNA expression for ETRAMP10.2, GAPDH, and EF1&#945; (&gt;4,000 RPKM summed on all blood stages; Otto <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0058" ref-type="ref">2014</xref>), we assumed that the different immunodominance profile may be caused by an earlier onset of GAPDH and EF1&#945; expression during pre&#8208;erythrocytic stages. We also hypothesized that the ETRAMP&#8208;specific response might inflate later during blood stage developing after spz infection. To test this possibility, we treated spz&#8208;infected mice at days 6 and 7 with chloroquine (CQ) in order to prevent ECM mortality but without totally blunting blood&#8208;stage development (Fig&#160;<xref rid="emmm201708123-fig-0003" ref-type="fig">3</xref>A and C). We could then analyze the CD4 responses at day 14 pi, when parasitemia had reached a similar level as day 8 without CQ (Fig&#160;<xref rid="emmm201708123-fig-0003" ref-type="fig">3</xref>C). In these conditions, the ETRAMP peptide was immunodominant (Fig&#160;<xref rid="emmm201708123-fig-0003" ref-type="fig">3</xref>D).</p><fig fig-type="Figure" xml:lang="en" id="emmm201708123-fig-0003" orientation="portrait" position="float"><label>Figure 3</label><caption><title>Immunodominance of <italic>Pb</italic>A&#8208;derived <styled-content style="fixed-case">MHC II</styled-content> peptides during blood&#8208;stage malaria induced after spz infection</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0004"><list-item><p>Experimental protocol used to analyze the <italic>ex&#160;vivo</italic> T&#8208;cell responses in the spleen at day 8 and 14 following spz inoculation, with or without chloroquine (CQ) treatment as indicated.</p></list-item><list-item><p>IFN&#947;/TNF&#8208;double&#8208;producing cells among activated CD4 T cells, after subtracting the basal level with MutuDC alone (mean&#160;&#177;&#160;SEM). Asterisks show statistical significance assessed by paired nonparametric Wilcoxon tests in comparison with OVA peptide. AMA1, *<italic>P</italic>&#160;=&#160;0.027; TIM14, <italic>P</italic>&#160;=&#160;0.84; ENO, <italic>P</italic>&#160;=&#160;0.84; GAPDH.1, *<italic>P</italic>&#160;=&#160;0.002; MAHRP, <italic>P</italic>&#160;=&#160;0.71; EF1&#945;, *<italic>P</italic>&#160;=&#160;0.001; M1, *<italic>P</italic>&#160;=&#160;0.032; MSP1, <italic>P</italic>&#160;=&#160;0.23; *LDH, <italic>P</italic>&#160;=&#160;0.016; ETRAMP, <italic>P</italic>&#160;=&#160;0.064; ATPSYN, <italic>P</italic>&#160;=&#160;0.77; END70, <italic>P</italic>&#160;=&#160;0.097; PDI, *<italic>P</italic>&#160;=&#160;0.0052; GAPDH.2, <italic>P</italic>&#160;=&#160;0.19; pRBC, *<italic>P</italic>&#160;=&#160;0.001. <italic>N</italic>&#160;=&#160;15 mice pooled from three replicates.</p></list-item><list-item><p>Blood parasitemia (mean&#160;&#177;&#160;SEM) monitored by flow cytometry after inoculation of 5&#160;&#215;&#160;10<sup>4</sup>
<italic>Pb</italic>A.GFP spz in B6 mice, treated (open squares) or not (black squares) with CQ at day 6 and 7&#160;pi, in order to avoid ECM without blunting infection. Day 6, <italic>P</italic>&#160;=&#160;0.29; Day 7, *<italic>P</italic>&#160;=&#160;0.0013 by multiple unpaired <italic>t</italic>&#8208;tests.</p></list-item><list-item><p>IFN&#947;/TNF&#8208;double&#8208;producing cells among activated CD4 T cells, at day 14&#160;pi following CQ treatment (mean&#160;&#177;&#160;SEM). Basal level with MutuDC alone was subtracted. GAPDH.1, <italic>P</italic>&#160;=&#160;0.99; EF1&#945;, <italic>P</italic>&#160;=&#160;0.062; ETRAMP, *<italic>P</italic>&#160;=&#160;0.031; pRBC, *<italic>P</italic>&#160;=&#160;0.031 by paired nonparametric Wilcoxon tests in comparison with OVA peptide.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-13" xlink:href="EMMM-9-1605-g006"/></fig><p>In summary, our results indicate (i) that CD4 immunodominance hierarchy during blood stage is dictated in part by the route of challenge and by the duration of blood&#8208;stage infection and (ii) that ETRAMP ultimately establishes as a prominent blood&#8208;stage peptide after both spz and pRBC infections.</p></sec><sec id="emmm201708123-sec-0005"><title>cDC1 are superior to cDC2 for I&#8208;A<sup>b</sup> presentation of malaria antigens</title><p>Next, we wanted to address which APC subset(s) control the generation of parasite&#8208;specific CD4 T cells by presenting malaria antigens on MHC II. We set out to generate reporter CD4 T&#8208;cell hybridomas recognizing the dominant ETRAMP10.2 peptide, but as mentioned, MHC II ligands can be diverse in size (12&#8211;25 aa) and contain various N&#8208; and C&#8208;terminal extensions. To choose the optimal ETRAMP&#8208;derived peptide for raising the hybridomas, we assessed the ability of CD4 T cells from <italic>Pb</italic>A&#8208;infected mice to recognize N&#8208; and C&#8208;terminally extended versions of the NL17 peptide (Fig&#160;<xref rid="emmm201708123-fig-0003ev" ref-type="fig">EV3</xref>A). As NL17 was among the most stimulatory peptides (Fig&#160;<xref rid="emmm201708123-fig-0003ev" ref-type="fig">EV3</xref>B), we proceeded to generate NL17&#8208;specific T&#8208;cell hybridomas, that we named B6&#8208;derived CD4 T&#8208;cell hybrids reactive to ETRAMP and producing LacZ (BEZ). We confirmed that BEZ hybridomas reacted to <italic>Pb</italic>A pRBC&#8208; but not to uninfected RBC&#8208;loaded DC (Fig&#160;<xref rid="emmm201708123-fig-0003ev" ref-type="fig">EV3</xref>C), and we observed that BEZ detected down to 2 nM of NL17 synthetic peptide (Fig&#160;<xref rid="emmm201708123-fig-0003ev" ref-type="fig">EV3</xref>D).</p><fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="emmm201708123-fig-0003ev" orientation="portrait" position="float"><label>Figure EV3</label><caption><title>
<styled-content style="fixed-case">ETRAMP</styled-content>10.2 <styled-content style="fixed-case">NL</styled-content>17 peptide is optimal for restimulating <styled-content style="fixed-case">CD</styled-content>4 T cells from <italic>Pb</italic>A&#8208;infected mice and is stimulatory to <styled-content style="fixed-case">BEZ</styled-content> hybridomas</title><p>
<list list-type="simple" id="emmm201708123-list-0009"><list-item><label>A</label><p>N&#8208; and C&#8208;terminally extended versions of the ETRAMP10.2 peptide used to restimulate CD4 T cells from infected mice <italic>ex&#160;vivo</italic>.</p></list-item><list-item><label>B</label><p>IFN&#947;/TNF&#8208;double&#8208;producing cells among activated CD4 T cells (mean&#160;&#177;&#160;SEM) responding to MutuDC pulsed with the indicated peptide variants, evaluated at day 6 post&#8208;infection with <italic>Pb</italic>A pRBC. <italic>N</italic>&#160;=&#160;3 mice.</p></list-item><list-item><label>C,D</label><p>Responsiveness of BEZ hybridomas: B6&#8208;derived hybrids reactive to ETRAMP10.2 peptide and producing LacZ. &#946;&#8208;galactosidase production by BEZ after stimulation with MutuDC loaded with RBC or <italic>Pb</italic>A pRBC (C) or with MutuDC incubated with serially diluted ETRAMP10.2 NL17 peptide (D). Representative of two replicates.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-15" xlink:href="EMMM-9-1605-g007"/></fig><p>To define the APC subset(s) presenting the ETRAMP10.2 peptide, we FACS&#8208;sorted three splenic DC subsets (cDC1, cDC2, pDC) and a 4<sup>th</sup> mixed population containing macrophages and monocyte&#8208;derived DC (moDC) from day 6&#8208;infected mice (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>A) and used them in a BEZ antigen presentation assay. cDC1 were the most potent APC and were as stimulatory as <italic>Pb</italic>A pRBC&#8208;loaded MutuDC (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>B). cDC2 were able to present the ETRAMP peptide albeit at much lower levels. We could not detect any presentation by pDC or by the macrophage/moDC mixed population (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>B). The lower performance of cDC2 cannot be explained by impaired I&#8208;A<sup>b</sup> expression since I&#8208;A<sup>b</sup> was slightly more abundant on cDC2 in day 6&#8208;infected mice (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>C). Furthermore, when cDC1 and cDC2 were exogenously loaded with AS15, an I&#8208;A<sup>b</sup> peptide from <italic>T.&#160;gondii</italic> (Grover <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0029" ref-type="ref">2012</xref>), there was no difference in hybridoma stimulation at high peptide concentration (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>D). The difference between cDC1 and cDC2 in Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>B is likely due to other factors, potentially including a different phagocytosis capacity and/or a different processing efficiency. Following incubation with heat&#8208;killed <italic>T.&#160;gondii</italic> (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>E) and OVA&#8208;expressing <italic>E.&#160;coli</italic> bacteria (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>F), cDC1 were indeed more potent for processing and presenting these exogenous antigens on MHC II. To evaluate the phagocytosis potential of these two DC subsets, we infected mice with <italic>Pb</italic>A.GFP and measured the proportion of GFP<sup>+</sup> cells among cDC1. This proportion was about twice as high as that among cDC2, suggesting that cDC1 possess a better pRBC uptake capacity <italic>in&#160;vivo</italic> (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>G). To analyze whether the selective cDC1 superiority was specifically related to severe malaria, we isolated cDC1 and cDC2 from na&#239;ve mice and exposed them to <italic>Pb</italic>A pRBC (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>H) and to OVA&#8208;expressing <italic>E.&#160;coli</italic> (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>I). In both contexts, cDC1 performed better than cDC2, and again, this was not due to a reduced MHC II surface expression (Fig&#160;<xref rid="emmm201708123-fig-0004" ref-type="fig">4</xref>J).</p><fig fig-type="Figure" xml:lang="en" id="emmm201708123-fig-0004" orientation="portrait" position="float"><label>Figure 4</label><caption><title>
<styled-content style="fixed-case">cDC</styled-content>1 are superior to other spleen antigen&#8208;presenting cells for <styled-content style="fixed-case">MHC II</styled-content> presentation of <italic>Pb</italic>A and non&#8208;<italic>Pb</italic>A antigens</title><p>
<list list-type="simple" id="emmm201708123-list-0005"><list-item><label>A</label><p>Gating strategy for FACS&#8208;sorting pDC (Lin<sup>&#8722;</sup> CD11c<sup>lo</sup> B220<sup>+</sup> Ly6C<sup>+</sup>), cDC1 (Lin<sup>&#8722;</sup> CD11c<sup>+</sup> CD8&#945;<sup>+</sup>), cDC2 (Lin<sup>&#8722;</sup> CD11c<sup>+</sup> CD8&#945;<sup>&#8722;</sup>), and a mix of macrophages and moDC (Lin<sup>&#8722;</sup> CD11c<sup>&#8722;</sup> CD11b<sup>+</sup> Ly6C<sup>+</sup>) from spleens of mice infected for 6&#160;days with <italic>Pb</italic>A pRBC.</p></list-item><list-item><label>B</label><p>I&#8208;A<sup>b</sup> presentation of ETRAMP10.2 peptide by the indicated APC, measured with BEZ hybridomas. <italic>Pb</italic>A pRBC&#8208;loaded MutuDC were used as controls. Representative of two experiments with four infected mice pooled per replicate.</p></list-item><list-item><label>C</label><p>Fold&#8208;change surface expression of I&#8208;A<sup>b</sup> in cDC2 over cDC1 in day 6&#8208;infected mice (mean&#160;&#177;&#160;SEM of five experiments). Difference is not significant based on unpaired <italic>t</italic>&#8208;test with Welch's correction.</p></list-item><list-item><label>D&#8211;F</label><p>I&#8208;A<sup>b</sup> presentation of non&#8208;<italic>Pb</italic>A antigens by cDC isolated from day 6 <italic>Pb</italic>A&#8208;infected mice. (D) I&#8208;A<sup>b</sup>&#8208;AS15 presentation after exogenous addition of AS15 peptide at the indicated concentrations, assessed with the BTg01Z hybridomas. (E) I&#8208;A<sup>b</sup>&#8208;AS15 presentation by DC incubated with heat&#8208;killed <italic>T.&#160;gondii</italic> at the indicated ratio, assessed with the BTg01Z hybridomas. (F) I&#8208;A<sup>b</sup>&#8208;IR17 presentation by DC incubated with OVA&#8208;expressing <italic>E.&#160;coli</italic> at the indicated ratio, assessed with the OTIIZ hybridomas. <italic>Pb</italic>A pRBC&#8208;loaded MutuDC were used as controls. Representative of two experiments with four infected mice pooled per replicate. Dotted line shows the basal response of the hybridomas in the absence of antigen.</p></list-item><list-item><label>G</label><p>
<italic>In vivo</italic> pRBC uptake by cDC1 (XCR1<sup>+</sup> CD172a<sup>&#8722;</sup>) and cDC2 (XCR1<sup>&#8722;</sup> CD172a<sup>+</sup>) analyzed at 6 days post&#8208;infection with <italic>Pb</italic>A.GFP. Gates were positioned based on the auto&#8208;fluorescence of the cDC subset in day 6 <italic>Pb</italic>A&#8208;infected mice. As GFP<sup>+</sup> events are rare, 10<sup>7</sup> events were acquired for each mouse. Symbols show the mean percentage&#160;&#177;&#160;SEM (<italic>N</italic>&#160;=&#160;4 mice per group) of GFP<sup>+</sup> cells in each DC subset. *P = 0.0005 by unpaired <italic>t</italic>&#8208;test without assuming consistent SD.</p></list-item><list-item><label>H, I</label><p>I&#8208;A<sup>b</sup> presentation by cDC isolated from na&#239;ve mice. (H) I&#8208;A<sup>b</sup>&#8208;NL17 presentation by DC incubated with <italic>Pb</italic>A pRBC at a ratio of 5:1, assessed with the BEZ hybridomas. (I) I&#8208;A<sup>b</sup>&#8208;IR17 presentation by DC incubated with OVA&#8208;expressing <italic>E.&#160;coli</italic> at a ratio of 20:1, assessed with the OTIIZ hybridomas. Representative of two independent experiments with 20 na&#239;ve mice pooled per experiment. Dotted line shows the basal response of the hybridomas in the absence of antigen.</p></list-item><list-item><label>J</label><p>Fold&#8208;change surface expression of I&#8208;A<sup>b</sup> in cDC2 over cDC1 in na&#239;ve mice (mean&#160;&#177;&#160;SEM of four experiments). Difference is not significant based on unpaired <italic>t</italic>&#8208;test with Welch's correction.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-17" xlink:href="EMMM-9-1605-g008"/></fig><p>Altogether, these data show that both in na&#239;ve mice and during severe <italic>Pb</italic>A malaria, cDC2 are selectively impeded in MHC II processing and presentation of pRBC&#8208;derived antigens as compared to cDC1, most likely leading to cDC1 playing prominent MHC II&#8208;related functions <italic>in&#160;vivo</italic>.</p></sec><sec id="emmm201708123-sec-0006"><title>cDC1 regulate CD4 T&#8208;cell functionality during severe malaria</title><p>To decipher the <italic>in&#160;vivo</italic> implication of cDC1 in activating CD4 T cells, we took advantage of <italic>Karma</italic> mice that allow conditional depletion of cDC1 upon injection of DT (Alexandre <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0001" ref-type="ref">2016</xref>). We first verified that DT treatment had no adverse effect on the development of parasitemia and on parasite&#8208;specific Th1 responses (data not shown). We started the DT treatment prior to infection and maintained the depletion throughout blood&#8208;stage development using repeated DT injections (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>A). At day 6 pi, a clear reduction in CD8&#945;<sup>+</sup> DC was observed (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>B and C) even though it appeared less pronounced than what is achieved at steady state (Alexandre <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0001" ref-type="ref">2016</xref>). Regardless of the cause for this partial depletion (e.g. influence of infection on cDC1 survival and/or differentiation), we confirmed a previous study reporting that cDC1 promote the development of <italic>Pb</italic>A&#8208;specific CD8 responses (Piva <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0062" ref-type="ref">2012</xref>). The numbers of CD8 T cells responding to <italic>Pb</italic>A pRBC&#8208;loaded MutuDC, as well as to the F4 (Lau <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0045" ref-type="ref">2011</xref>) and GAP50 (Howland <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0038" ref-type="ref">2013</xref>) MHC I epitopes, were indeed substantially lower in DT&#8208;treated <italic>Karma</italic> mice (Fig&#160;<xref rid="emmm201708123-fig-0004ev" ref-type="fig">EV4</xref>A). Most remarkably, cDC1 ablation resulted in dramatically impaired proportions (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>D and E) and numbers (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>F) of CD4 T cells co&#8208;producing IFN&#947; and TNF in response to <italic>Pb</italic>A pRBC&#8208;loaded or peptide&#8208;pulsed MutuDC. The same was true at day 4 post&#8208;infection (Fig&#160;<xref rid="emmm201708123-fig-0004ev" ref-type="fig">EV4</xref>B) indicating that cDC1 are not only important for maintenance of IFN&#947;<sup>+</sup> TNF<sup>+</sup> Th1 cells but also for their priming. The effect of cDC1 depletion on the development of Th1 CD4 responses was not the mere consequence of altered parasite growth as blood parasitemia was comparable with and without DT treatment (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>G). The reduced differentiation into IFN&#947;<sup>+</sup> TNF<sup>+</sup> CD4 T cells was also accompanied by further changes in the functionality of parasite&#8208;specific CD4 T cells. Multifunctional analysis of IFN&#947;, TNF, IL&#8208;10 single, double, and triple producers performed on CD4 T cells responding to pRBC&#8208;loaded MutuDC (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>H) showed an increased proportion of single IL&#8208;10<sup>+</sup> CD4 T cells in DT&#8208;treated mice (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>I). Restimulation with the three most dominant peptides also led to higher proportions of IL&#8208;10<sup>+</sup> Tr1 cells in DT&#8208;treated mice (Fig&#160;<xref rid="emmm201708123-fig-0005" ref-type="fig">5</xref>J).</p><fig fig-type="Figure" xml:lang="en" id="emmm201708123-fig-0005" orientation="portrait" position="float"><label>Figure 5</label><caption><title>
<styled-content style="fixed-case">cDC</styled-content>1 are required for the development of parasite&#8208;specific <styled-content style="fixed-case">IFN</styled-content>&#947;<sup>+</sup>
<styled-content style="fixed-case">TNF</styled-content>
<sup>+</sup> Th1 responses during <italic>Pb</italic>A blood&#8208;stage malaria</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0006"><list-item><p>Experimental protocol to analyze T&#8208;cell responses in <italic>Karma</italic> mice at day 6 post&#8208;infection with <italic>Pb</italic>A pRBC. Mice were injected with DT prior to infection and repeatedly every 60 h thereafter.</p></list-item><list-item><p>Gating strategy to assess efficiency of cDC1 depletion.</p></list-item><list-item><p>Percentage (mean&#160;&#177;&#160;SEM) of CD8&#945;<sup>+</sup> out of Lin<sup>&#8722;</sup> B220<sup>&#8722;</sup> CD11c<sup>+</sup> MHC II<sup>hi</sup> cells. *<italic>P</italic>&#160;=&#160;0.0043 by Mann&#8211;Whitney test. No DT group, <italic>N</italic>&#160;=&#160;5 mice; + DT group, <italic>N</italic>&#160;=&#160;6 mice. Representative of three independent experiments.</p></list-item><list-item><p>FACS plots showing the proportion of CD11a<sup>+</sup> CD49d<sup>+</sup> CD4 T cells that produce IFN&#947; and TNF in response to MutuDC loaded with RBC, <italic>Pb</italic>A pRBC, or ETRAMP10.2 peptide.</p></list-item><list-item><p>Proportion of CD11a<sup>+</sup> CD49d<sup>+</sup> CD4 T cells that co&#8208;produce IFN&#947; and TNF (mean&#160;&#177;&#160;SEM) in response to MutuDC loaded with the indicated antigen, isolated from <italic>Karma</italic> mice treated (open circles) or not (black circles) with DT. Asterisks show significant differences between no DT and + DT group by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD. RBC, <italic>P</italic>&#160;=&#160;0.18; GAPDH.1, *<italic>P</italic>&#160;=&#160;0.019; EF1a, *<italic>P</italic>&#160;=&#160;0.039; ETRAMP, *<italic>P</italic>&#160;=&#160;0.00054; OVA, <italic>P</italic>&#160;=&#160;0.25; pRBC, *<italic>P</italic>&#160;=&#160;0.015. No DT group, <italic>N</italic>&#160;=&#160;5 mice; + DT group, <italic>N</italic>&#160;=&#160;6 mice. Representative of three independent experiments.</p></list-item><list-item><p>Absolute numbers of IFN&#947;<sup>+</sup> TNF<sup>+</sup> CD11a<sup>+</sup> CD49d<sup>+</sup> CD4<sup>+</sup> T cells responding to the indicated stimuli (mean&#160;&#177;&#160;SEM). GAPDH.1, *<italic>P</italic>&#160;=&#160;0.0047; EF1a, *<italic>P</italic>&#160;=&#160;0.00039; ETRAMP, *<italic>P</italic>&#160;=&#160;0.00022; pRBC, *<italic>P</italic>&#160;=&#160;0.00019 by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD. No DT group, <italic>N</italic>&#160;=&#160;5 mice; + DT group, <italic>N</italic>&#160;=&#160;6 mice. Representative of three independent experiments.</p></list-item><list-item><p>Blood parasitemia (mean&#160;&#177;&#160;SEM) at day 4 and 6&#160;pi in <italic>Karma</italic> mice treated (open circles) or not (black circles) with DT. Day 4, *<italic>P</italic>&#160;=&#160;0.022; Day 6, <italic>P</italic>&#160;=&#160;0.77 by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD. No DT group, <italic>N</italic>&#160;=&#160;5 mice; + DT group, <italic>N</italic>&#160;=&#160;6 mice. Representative of three independent experiments.</p></list-item><list-item><p>Absolute numbers of CD4<sup>+</sup> T cells producing IFN&#947;, TNF, or IL&#8208;10, either individually or in combination, following restimulation with MutuDC+<italic>Pb</italic>A pRBC (mean&#160;&#177;&#160;SEM). These cells are called cytokine<sup>+</sup> in the next panels. *<italic>P</italic>&#160;=&#160;0.0023 by unpaired <italic>t</italic>&#8208;test without assuming consistent SD. <italic>N</italic>&#160;=&#160;3 mice per group.</p></list-item><list-item><p>Multifunctionality analysis (IFN&#947;, TNF, IL&#8208;10) of cytokine<sup>+</sup> T cells responding to MutuDC loaded with <italic>Pb</italic>A pRBC. <italic>N</italic>&#160;=&#160;3 mice per group.</p></list-item><list-item><p>Proportion of IL&#8208;10<sup>+</sup> IFN&#947;<sup>&#8722;</sup> TNF<sup>&#8722;</sup> among cytokine<sup>+</sup> T cells, in response to MutuDC loaded with the indicated antigen (mean&#160;&#177;&#160;SEM). GAPDH.1, <italic>P</italic>&#160;=&#160;0.32; EF1a, <italic>P</italic>&#160;=&#160;0.16; ETRAMP, **<italic>P</italic>&#160;=&#160;8.5&#160;&#215;&#160;10<sup>&#8722;5</sup>; OVA, <italic>P</italic>&#160;=&#160;0.11; **pRBC, <italic>P</italic>&#160;=&#160;0.0015 by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD. <italic>N</italic>&#160;=&#160;3 mice per group.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-19" xlink:href="EMMM-9-1605-g010"/></fig><fig fig-type="Figure" xml:lang="en" specific-use="collapsible" id="emmm201708123-fig-0004ev" orientation="portrait" position="float"><label>Figure EV4</label><caption><title>
<styled-content style="fixed-case">cDC</styled-content>1 are required for the generation of parasite&#8208;specific <styled-content style="fixed-case">CD</styled-content>8 T cells and the priming of <styled-content style="fixed-case">CD</styled-content>4 Th1 cells during <italic>Pb</italic>A blood&#8208;stage malaria</title><p>
<list list-type="alpha-upper" id="emmm201708123-list-0010"><list-item><p>Absolute numbers of IFN&#947;<sup>+</sup> TNF<sup>+</sup> CD11a<sup>+</sup> CD49d<sup>+</sup> CD8<sup>+</sup> responding to MutuDC loaded with the indicated antigens, from <italic>Karma</italic> mice treated (open circles) or not (black circles) with DT, analyzed at day 6 post&#8208;infection (mean&#160;&#177;&#160;SEM). &#8220;No DT&#8221; group: <italic>N</italic>&#160;=&#160;5 mice, &#8220;+ DT&#8221; group: <italic>N</italic>&#160;=&#160;6 mice. GAP50, <italic>P</italic>&#160;=&#160;0.10; F4, <italic>P</italic>&#160;=&#160;0.14; pRBC, *<italic>P</italic>&#160;=&#160;6.45&#160;&#215;&#160;10<sup>&#8722;6</sup> by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD.</p></list-item><list-item><p>Proportion of CD11a<sup>+</sup> CD49d<sup>+</sup> CD4 T cells that co&#8208;produce IFN&#947; and TNF in response to MutuDC loaded with the indicated antigens, from <italic>Karma</italic> mice treated (open circles) or not (black circles) with DT, analyzed at day 4 post&#8208;infection (mean&#160;&#177;&#160;SEM). &#8220;No DT&#8221; group: <italic>N</italic>&#160;=&#160;3 mice, &#8220;+ DT&#8221; group: <italic>N</italic>&#160;=&#160;4 mice. Asterisks show significant differences by multiple unpaired <italic>t</italic>&#8208;tests without assuming consistent SD. RBC, *<italic>P</italic>&#160;=&#160;0.033; GAPDH.1, <italic>P</italic>&#160;=&#160;0.36; EF1a, <italic>P</italic>&#160;=&#160;0.14; ETRAMP, *<italic>P</italic>&#160;=&#160;0.01; OVA, <italic>P</italic>&#160;=&#160;0.18; pRBC, *<italic>P</italic>&#160;=&#160;0.017.</p></list-item></list>
</p></caption><graphic id="nlm-graphic-21" xlink:href="EMMM-9-1605-g009"/></fig><p>In conclusion, our data demonstrate that in the context of severe blood&#8208;stage malaria, cDC1 promote the differentiation of parasite&#8208;specific IFN&#947;<sup>+</sup> TNF<sup>+</sup> Th1 cells, to the expense of more regulatory IL&#8208;10<sup>+</sup> CD4 T cells.</p></sec></sec><sec id="emmm201708123-sec-0007"><title>Discussion</title><p>In malaria&#8208;endemic areas, a nagging issue is the failure of naturally exposed individuals to develop sterile long&#8208;lasting protective immunity. This may be due to several factors including the stage specificity of parasite antigen expression, the antigenic variability among field parasites, and the profound immune dysregulation caused by pre&#8208;erythrocytic and erythrocytic stages (Renia &amp; Goh, <xref rid="emmm201708123-bib-0068" ref-type="ref">2016</xref>; Scholzen &amp; Sauerwein, <xref rid="emmm201708123-bib-0073" ref-type="ref">2016</xref>; Van Braeckel&#8208;Budimir <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0085" ref-type="ref">2016</xref>). These factors could also contribute to explain why despite tremendous investments and years of research, progress on the vaccination front has been only modest. Clinical efficacy of the most advanced subunit vaccine candidate against <italic>P.&#160;falciparum</italic> (RTS,S) is limited and quickly wanes over time (Olotu <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0057" ref-type="ref">2016</xref>). Hopes are emerging from whole attenuated sporozoite vaccination strategies (Sissoko <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0076" ref-type="ref">2017</xref>), but the disappointing RTS,S results combined with the fact that vaccine research on <italic>P.&#160;vivax</italic> is only beginning (Tham <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0084" ref-type="ref">2017</xref>) suggest the need to broaden our search for new subunit vaccine candidates and to dramatically improve the candidate down&#8208;selection process.</p><p>Mouse models of malaria are not faithful in every aspect to human malaria pathology, but they represent useful tools to establish proofs&#8208;of&#8208;concept, for example, related to immunomics approaches. Using <italic>P.&#160;berghei</italic> infection in B6 mice, our study shows a selective superiority of cDC1 in MHC II presentation of pRBC&#8208;associated antigens at ECM onset, that is, day 6 post&#8208;infection. DC functions are known to be impeded during blood&#8208;stage malaria (Cockburn &amp; Zavala, <xref rid="emmm201708123-bib-0015" ref-type="ref">2016</xref>), and one can imagine that malaria may more strongly impact cDC2. However, our finding that cDC1 from na&#239;ve mice also present pRBC&#8208;derived antigens better than cDC2 suggests that this difference is not, or at least not solely, dictated by infection. Using a CD4 T&#8208;cell hybridoma that recognizes a currently undefined <italic>Plasmodium</italic> epitope, a Biorxiv&#8208;posted study (Fernandez&#8208;Ruiz <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0200" ref-type="ref">2017</xref>) reports that cDC1 are more stimulatory than CD4<sup>+</sup> DC and double&#8208;negative DC, both in na&#239;ve mice and at 3&#160;days post&#8208;infection. Although the sensitivity of our hybridomas did not allow us to evaluate the ETRAMP10.2 MHC II presentation at such an early time point (data not shown), our data are consistent with this work. What mechanism(s) could account for such a difference in MHC II presentation? One possibility is that cDC1 are equipped with a better pRBC uptake capability, which is supported by our evaluation of pRBC uptake in day 6&#8208;infected mice. In line with this idea, the phagocytic potential of cDC2 is specifically suppressed by type I IFN signaling during <italic>Pb</italic>A infection (Haque <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0033" ref-type="ref">2014</xref>). Another non&#8208;mutually exclusive hypothesis is a difference in the efficiency of the MHC II processing pathway. Phagolysosome maturation and/or hydrolase activity in MHC II processing compartments could be selectively enhanced in cDC1 and/or dysfunctional in cDC2. Alternatively, antioxidant pathways involving heme oxygenase&#8208;1, which are known to affect antigen presentation by DC (Riquelme <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0069" ref-type="ref">2015</xref>), may be differentially elicited in cDC1 <italic>vs</italic> cDC2. Dissecting how malaria antigens are processed differentially for MHC II presentation in DC subsets, and how severe malaria regulates this process, represents exciting avenues of future research.</p><p>A second substantial finding is that during severe malaria, cDC1 are critical for priming and promoting parasite&#8208;specific Th1 CD4 T cells. This is consistent with the results of a study using a CD4 TCR&#8208;transgenic mouse specific for a <italic>Plasmodium</italic> epitope (Fernandez&#8208;Ruiz <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0200" ref-type="ref">2017</xref>). More generally, these data are in line with the established propensity of cDC1 to secrete IL&#8208;12 during infection by intracellular pathogens (Mashayekhi <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0053" ref-type="ref">2011</xref>; Alexandre <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0001" ref-type="ref">2016</xref>) and the implication of cDC1 in Th1 polarization during other parasitic infections such as leishmaniasis (Ashok <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0003" ref-type="ref">2014</xref>; Martinez&#8208;Lopez <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0052" ref-type="ref">2015</xref>) and toxoplasmosis (Mashayekhi <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0053" ref-type="ref">2011</xref>). Perhaps most importantly, we find that cDC1 depletion, possibly by &#8220;forcing&#8221; MHC II presentation by the remaining cDC2 subset, skews cytokine production of parasite&#8208;specific CD4 T cells toward a more regulatory profile, associated with a higher proportion of single IL&#8208;10&#8208;producing CD4 T cells. This supports the emerging and prominent concept that functional polarization of CD4 Th cells is in part dictated by the subset(s) of cDC activating the CD4 T cells (Dutertre <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0021" ref-type="ref">2014</xref>; Vu Manh <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0089" ref-type="ref">2015</xref>). For instance, while IRF4 deficiency (resulting in impaired migration of cDC2) abrogates Th17 responses upon fungal challenge, Batf3 deficiency (resulting in lack of cDC1) skews CD4 responses toward Tregs and Th2, ultimately perturbing <italic>Leishmania</italic> parasite control (Ashok <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0003" ref-type="ref">2014</xref>). In a non&#8208;infectious context, a mouse model of type I diabetes, targeting of a pancreatic cell antigen to cDC2 favors tolerogenic properties by autoreactive CD4 T cells as compared to cDC1 targeting (Price <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0065" ref-type="ref">2015</xref>). Given the major regulatory role of IL&#8208;10 produced by CD4 Th cells during <italic>Pcc</italic> infection (Freitas do Rosario &amp; Langhorne, <xref rid="emmm201708123-bib-0026" ref-type="ref">2012</xref>), one could speculate that the sustained antigen presentation by cDC2 in this setting (Sponaas <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0080" ref-type="ref">2006</xref>) is involved in preventing immunopathology. In turn, one could hypothesize that addition of cDC2 or restoration of cDC2 MHC II presentation during <italic>Pb</italic>A infection may mirror cDC1 depletion and enhance the differentiation of regulatory Tr1 cells, which could ultimately alleviate ECM immunopathology. Harnessing DC subsets for immunotherapy of rheumatoid diseases (Pozsgay <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0064" ref-type="ref">2017</xref>) and autoimmune pathologies (Liu &amp; Cao, <xref rid="emmm201708123-bib-0047" ref-type="ref">2015</xref>; Audiger <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0004" ref-type="ref">2017</xref>) is already a major research area. Modulating cDC1 to curtail excessive Th1 responses in human severe malaria could represent a valuable translational approach.</p><p>So far at least eight MHC I epitopes were characterized in B6 mice infected with <italic>Pb</italic>A (Lau <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0045" ref-type="ref">2011</xref>, <xref rid="emmm201708123-bib-0046" ref-type="ref">2014</xref>; Howland <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0038" ref-type="ref">2013</xref>; Poh <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0063" ref-type="ref">2014</xref>), but no CD4 T&#8208;cell epitope was known. By characterizing the MHC II immunopeptidome by MS/MS, our study identifies a panel of MHC II ligands able to restimulate CD4 T cells isolated from <italic>Pb</italic>A&#8208;infected mice. <italic>Pb</italic>A infection is suited to evaluate the role of DC on T&#8208;cell polarization and pathogenicity during cerebral malaria, but this acute model is not well adapted to study the effects of CD4&#8208;dependent antibody responses on parasitemia. As previously reported (Piva <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0062" ref-type="ref">2012</xref>), we observed no major effect of cDC1 depletion on parasite growth. <italic>Pcc</italic> and <italic>Pb</italic> NK65 &#916;HRF are likely to be better models to evaluate the relevance of the identified peptides on parasitemia and antibody&#8208;mediated protection. While our study does not analyze these aspects, we found that some peptides were recognized by CD4 T cells isolated from <italic>Pcc</italic>&#8208;infected mice and mice immunized with the <italic>Pb</italic> NK65 &#916;HRF GAP, thus setting the stage to assess (i) whether the conserved peptides will elicit protection after challenge with <italic>Pcc</italic> and (ii) whether the protective antibody responses generated by the <italic>Pb</italic> NK65 &#916;HRF vaccine GAP target the same MHC II antigens. Among the unraveled antigen panel, two of them may be particularly relevant to further analyze: ETRAMP10.2 and GAPDH. ETRAMP10.2 belongs to a family of proteins present in mouse and human <italic>Plasmodium</italic> that is secreted and anchored at the parasitophorous vacuole membrane (Spielmann <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0079" ref-type="ref">2003</xref>; Pasini <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0059" ref-type="ref">2013</xref>). Interestingly, ETRAMP10.2 and other members (ETRAMP2, 4 and 10.1) are recognized by immunoglobulins from individuals living in a high&#8208;endemicity malaria region of Papua New Guinea (Spielmann <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0079" ref-type="ref">2003</xref>) and ETRAMP11.2 is recognized by sera from &gt;&#160;80% of <italic>P.&#160;vivax</italic>&#8208;exposed individuals (Chen <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0013" ref-type="ref">2015</xref>), showing that ETRAMPs are relevant B&#8208;cell antigens in humans. GAPDH is primarily involved in glycolysis, but this enzyme also functions in processes ranging from DNA repair to membrane trafficking, iron transport, and cell signaling (Perez&#8208;Casal &amp; Potter, <xref rid="emmm201708123-bib-0060" ref-type="ref">2016</xref>). Akin to other housekeeping proteins, it had long been assumed that GAPDH was present exclusively in the cytoplasm, but accumulating evidence suggests that it is also present at the surface of pathogens such as <italic>Schistosoma mansoni</italic> helminths (Argiro <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0002" ref-type="ref">2000</xref>) and <italic>Streptococcus</italic> bacteria, where it could modulate virulence (Jin <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0043" ref-type="ref">2011</xref>). Interestingly, resistance to <italic>S.&#160;mansoni</italic> reinfection was found to correlate with serum reactivity toward a GAPDH epitope (Argiro <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0002" ref-type="ref">2000</xref>). In this context, GAPDH has been proposed as a vaccine candidate in several infectious settings and animal models (Perez&#8208;Casal &amp; Potter, <xref rid="emmm201708123-bib-0060" ref-type="ref">2016</xref>). During malaria, GAPDH is expressed during asexual blood stage at the apical end of merozoites where it may be involved in membrane trafficking and vesicular transport (Daubenberger <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0017" ref-type="ref">2003</xref>). Analysis of the surface&#8208;exposed spz proteome (Swearingen <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0083" ref-type="ref">2016</xref>) and immunofluorescence assays (Cha <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0012" ref-type="ref">2016</xref>) revealed that GAPDH is expressed on the surface of <italic>P.&#160;falciparum</italic> and of <italic>P.&#160;berghei</italic> spz. Notably, surface GAPDH interacts with CD68 expressed on Kupffer cells and is involved in liver invasion (Cha <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0012" ref-type="ref">2016</xref>). Furthermore, immunization of Swiss&#8208;Webster mice with KLH&#8208;coupled GAPDH conferred protection after spz challenge (Cha <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0012" ref-type="ref">2016</xref>). Knowing that the GAPDH GS18 epitope is conserved in <italic>Pb</italic>A, <italic>Pb</italic>K173, <italic>Pb</italic>NK65, <italic>Py</italic>17XNL, and <italic>Pcc</italic>, it seems relevant to further investigate the value of GAPDH as a multistage invasion&#8208;blocking vaccine candidate in pre&#8208;clinical mouse models. Our data also suggest analyzing whether natural antibody responses targeting <italic>Plasmodium</italic> GAPDH in humans are associated with a certain degree of immunity and/or clinical protection.</p><p>At last, our work provides a proof&#8208;of&#8208;concept supporting the relevance of profiling the HLA class II immunopeptidome for blood&#8208;stage <italic>P.&#160;falciparum</italic>. The biological and mass spectrometry techniques to analyze immunopeptidomes are rapidly evolving (Caron <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0011" ref-type="ref">2015</xref>) and methods to characterize HLA DR&#8208;bound immunopeptidomes with relatively low numbers of cells have been optimized (Heyder <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0035" ref-type="ref">2016</xref>), supporting the feasibility of this approach in human malaria. We expect this to lead to the identification of naturally processed epitopes recognized by CD4 T cells, including T<sub>FH,</sub> in infected humans. CD4 T cell help to CD8 T cells is needed to generate robust memory CD8 T cells (Janssen <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0042" ref-type="ref">2005</xref>), and the ability to generate fully functional T<sub>FH</sub> is critical for maintenance of effective long&#8208;term humoral immunity against malaria (Hansen <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0032" ref-type="ref">2017</xref>). Thus, applying this approach in human malaria may both uncover new vaccine targets and help us down&#8208;select vaccine candidates that are more likely to drive robust antibody responses through T<sub>FH</sub> restimulation and long&#8208;lasting CD8 T&#8208;cell memory differentiation through DC&#8208;integrated CD4 help.</p></sec><sec id="emmm201708123-sec-0008"><title>Materials and Methods</title><sec id="emmm201708123-sec-0009"><title>Ethics statement</title><p>Animal care and use protocols were carried out under the control of the National Veterinary Services and in accordance with the European regulations (EEC Council Directive, 2010/63/EU, September 2010). The protocol (CE no. 2015&#8208;03) was approved by the local Ethical Committee for Animal Experimentation (registered by the &#8220;Comit&#233; National de R&#233;flexion Ethique sur l'Exp&#233;rimentation Animale&#8221; under no. CEEA122).</p></sec><sec id="emmm201708123-sec-0010"><title>Mice, parasites, and experimental infections</title><p>C57BL/6J (B6) were purchased from Janvier (France), and <italic>Karma</italic> mice (<italic>a530099j19rik&#8208;</italic>
<sup><italic>tm1Ciphe</italic></sup>; Alexandre <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0001" ref-type="ref">2016</xref>) were imported from CIPHE, Marseille, France. All mice were males between 7 and 16&#160;weeks old. They were housed under specific pathogen&#8208;free conditions at UMS006&#8208;CREFRE, Toulouse. <italic>Plasmodium berghei</italic> ANKA (<italic>Pb</italic>A) and <italic>P.&#160;berghei</italic> Kyberg 173 (<italic>Pb</italic>K) parasites were propagated in B6. To prepare pRBC stocks, mice were bled in heparin and the proportion of pRBC was evaluated by blood smear. pRBC concentration was adjusted to 10<sup>7</sup> pRBC/ml in Grau solution (Alsever's solution with 10% glycerin), and 1&#160;ml aliquots were stored at &#8722;80&#176;C. All pRBC infections were done by intravenous inoculation of 10<sup>6</sup> pRBC, unless otherwise indicated. Sporozoites were obtained from salivary glands of <italic>Anopheles stephensi</italic> mosquitoes infected with <italic>Pb</italic>A expressing GFP under the HSP70 promoter, as described (Manzoni <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0051" ref-type="ref">2014</xref>). In brief, <italic>A.&#160;stephensi</italic> mosquitoes were reared at 26&#176;C and 80% humidity, and fed on 10% sucrose solution. Adult mosquitoes from 3 to 7&#160;days were fed on anesthetized <italic>Pb</italic>A&#8208;infected mice and further kept at 21&#176;C. Salivary glands of <italic>Pb</italic>A&#8208;infected mosquitoes were removed by hand dissection 21&#8211;28&#160;days post&#8208;feeding and crushed in Leibovitz's L&#8208;15 medium to release sporozoites. Parasites were counted and kept at 4&#176;C until use. Mice were infected i.v. with 5&#160;&#215;&#160;10<sup>4</sup> spz.</p><p>Parasitemia was measured by blood smear or flow cytometry with similar results. For flow cytometry, 3&#160;&#956;l of blood tail was collected using a microvette. With <italic>Pb</italic>A.GFP, the percentage of pRBC was determined by gating on GFP<sup>+</sup> out of total RBC on non&#8208;fixed blood. With non&#8208;fluorescent parasites, the blood was labeled with Ter119&#8208;FITC (1/30, Miltenyi Biotec), CD71&#8208;PE (C2, 1/300, BD Pharmingen) and CD41&#8208;PE&#8208;Cy7 (MWReg30, 1/100, Biolegend), fixed and permeabilized in 4% PFA and 0.6% saponin followed by DAPI staining. The percentage of pRBC was determined by gating on DAPI<sup>+</sup> out of Ter119<sup>+</sup> CD41<sup>&#8722;</sup> cells.</p></sec><sec id="emmm201708123-sec-0011"><title>MutuDC loading, I&#8208;A<sup>b</sup> immunoprecipitation, and peptide elution</title><p>pRBC from freshly harvested blood were enriched using Percoll in order to obtain &gt;&#160;70% parasitemia. 10<sup>8</sup> MutuDC were incubated overnight with 10<sup>9</sup>
<italic>Pb</italic>A or <italic>Pb</italic>K pRBC at 37&#176;C. Loaded DC were lysed using CHAPS buffer during 45&#160;min at 4&#176;C, as previously described (Bozzacco &amp; Yu, <xref rid="emmm201708123-bib-0008" ref-type="ref">2013</xref>). The lysate was cleared by centrifugation at 14,000&#160;<italic>g</italic> for 15&#160;min, and MHC II molecules were immunoprecipitated from the cleared lysate using 50&#160;&#956;g of Y&#8208;3P antibody (BioXCell) bound to protein&#8208;G beads overnight at 4&#176;C. Beads were washed 3 times, and peptides were eluted with 10% acetic acid at 70&#176;C for 10&#160;min.</p></sec><sec id="emmm201708123-sec-0012"><title>Western blot</title><p>Immunoprecipitation eluates were reduced in &#946;&#8208;mercaptoethanol and boiled or not in Laemmli buffer. Lysates corresponding to 7.5&#160;&#215;&#160;10<sup>5</sup> DC equivalents were separated by electrophoresis on 10% polyacrylamide gels and transferred to nitrocellulose membranes. Immunologic detection was achieved using primary rabbit anti&#8208;mouse I&#8208;A<sup>b</sup> (JV2, 1/1,000) followed by horseradish peroxidase&#8208;conjugated mouse anti&#8208;rabbit antibodies (Promega). Detection of&#160;peroxidase activity was achieved using a ChemiDoc system (Bio&#8208;Rad).</p></sec><sec id="emmm201708123-sec-0013"><title>Nano&#8208;LC&#8208;MS/MS analysis</title><p>Prior to analysis, peptides were separated from protein using a Vivaspin concentrator with 10&#8208;kDa MW cutoff. Peptides were subjected to solid&#8208;phase extraction using a C18 Sep&#8208;Pak cartridge and finally concentrated using a rotating evaporator. Nano&#8208;LC&#8208;MS/MS analysis was performed on an UltiMate 3000 RSLCnano System (Thermo Fisher Scientific) coupled to a Q&#8208;Exactive mass spectrometer (Thermo Fisher Scientific). Peptides were automatically fractionated onto a C18 reverse&#8208;phase column (75&#160;&#956;m&#160;&#215;&#160;150&#160;mm, 2&#160;&#956;m particle, PepMap100 RSLC column, Thermo Fisher Scientific) at a temperature of 35&#176;C. Trapping was performed during 4&#160;min at 5&#160;&#956;l/min, with solvent A (98% H<sub>2</sub>O, 2% ACN and 0.1% FA). Elution was performed using two solvents A (0.1% FA in water) and B (0.1% FA in ACN) at a flow rate of 300&#160;nl/min. Gradient separation was 36 min from 2% B to 40% B, 2 min to 90% B, and maintained for 5&#160;min. The column was equilibrated for 13&#160;min with 5% buffer B prior to the next sample analysis. The electrospray voltage was 1.9&#160;kV, and the capillary temperature was 275&#176;C. Full MS scans were acquired over m/z 400&#8211;2,000 range with resolution 70,000 (m/z 200). The target value was 10<sup>6</sup>. Ten most intense peaks with charge state between 2 and 7 were fragmented in the HCD collision cell with normalized collision energy of 35%, and tandem mass spectrum was acquired with resolution 35,000 at m/z 200. The target value was 2&#160;&#215;&#160;10<sup>5</sup>. The ion selection threshold was 6.7&#160;&#215;&#160;10<sup>4</sup> counts, and the maximum allowed ion accumulation times were 250&#160;ms for full MS scans and 150&#160;ms for tandem mass spectrum. Dynamic exclusion was set to 30&#160;s.</p></sec><sec id="emmm201708123-sec-0014"><title>Proteomic data analysis</title><p>Raw data collected during nano&#8208;LC&#8208;MS/MS analyses were processed and converted into *.mgf peak list format with Proteome Discoverer 1.4 (Thermo Fisher Scientific). MS/MS data were interpreted using search engine Mascot (version 2.4.1, Matrix Science, London, UK) installed on a local server. Searches were performed with a tolerance on mass measurement of 0.02 Da for precursor and 10&#160;ppm for fragment ions, against a composite target decoy database (189,576 total entries) built with <italic>Plasmodium berghei</italic> UniProt database (TaxID&#160;=&#160;5,823, December 3, 2015, 13,853 entries), <italic>Mus musculus</italic> UniProt database (TaxID&#160;=&#160;10,090, December 3, 2015, 78,986 entries) fused with the sequences of recombinant trypsin and a list of classical contaminants (117 entries). Methionine oxidation and protein N&#8208;terminal acetylation were searched as variable modifications, and no enzyme was indicated. For each sample, peptides were filtered out according to the cutoff set for proteins hits with 1 or more peptides taller than nine residues and ion score &gt;&#160;19, allowing a false&#8208;positive identification rate of 2.5% for protein and 0.4% for peptides.</p></sec><sec id="emmm201708123-sec-0015"><title>MHC purification and binding assays</title><p>Purification of I&#8208;A<sup>b</sup> MHC II molecules by affinity chromatography and the assay based on the inhibition of binding of a high&#8208;affinity radiolabeled peptide to quantitatively measure peptide binding were described elsewhere (Sidney <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0075" ref-type="ref">2013</xref>). Briefly, the mouse B&#8208;cell lymphoma LB27.4 was used as a source of MHC molecules. A high&#8208;affinity radiolabeled peptide (0.1&#8211;1&#160;nM; peptide ROIV, sequence YAHAAHAAHAAHAAHAA) was co&#8208;incubated at room temperature with purified MHC in the presence of a cocktail of protease inhibitors and an inhibitor peptide. Following a 2&#8208;day incubation, MHC&#8208;bound radioactivity was determined by capturing MHC/peptide complexes on mAb (Y3JP)&#8208;coated Lumitrac 600 plates (Greiner Bio&#8208;one), and measuring bound cpm using the TopCount (Packard Instrument Co) microscintillation counter. The concentration of peptide yielding 50% inhibition of the binding of the radiolabeled peptide was calculated. Under the conditions utilized, where [label]&#160;&lt;&#160;[MHC] and IC50&#160;&#8805;&#160;[MHC], the measured IC<sub>50</sub> values are reasonable approximations of the true K<sub>d</sub> values. Each competitor peptide was tested at six different concentrations covering a 100,000&#8208;fold range. The &#8220;cold&#8221; probe was used as a positive control in each experiment.</p></sec><sec id="emmm201708123-sec-0016"><title>Generation of reporter CD4 T&#8208;cell hybridomas</title><p>Mice were infected with <italic>Pb</italic>A pRBC and treated with intraperitoneal injections of 0.4&#160;mg of chloroquine (CQ) at days 3, 4, 5, and 6&#160;pi. Spleens were harvested at day 7&#160;pi, and 6&#160;&#215;&#160;10<sup>6</sup> splenocytes were seeded per well into a P24 in complete RPMI medium supplemented with 1&#160;&#956;M of ETRAMP NL17 peptide. After 2&#160;days, 50&#160;U/ml of recombinant human IL2 (rhIL2, BD Biosciences) was added. After 1&#160;week, cells were separated by Ficoll and CD4 T cells were enriched using magnetic sorting (Miltenyi). CD4 T cells were tested for reactivity and put back in culture with 35 Gray&#8208;irradiated MutuDC, 1&#160;&#956;M of NL17, 50&#160;U/ml rhIL2, and 5% of T&#8208;stim solution. Three days after, T&#8208;cell cultures were subjected to Ficoll separation and fused with the TCR&#945;&#946;&#8208;negative lacZ&#8208;inducible BWZ fusion partner, as previously described (Feliu <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0024" ref-type="ref">2013</xref>). Hybridomas were selected and subcloned at least 3 times. The reactivity was tested by mixing 10<sup>5</sup> hybridomas with 5&#160;&#215;&#160;10<sup>4</sup> MutuDC or BMDC, previously loaded with varying ratios of pRBC or RBC extracts overnight, or incubated with serially diluted NL17 peptide. RBC extracts were obtained by three freeze/thaw cycles (liquid nitrogen/37&#176;C).</p><p>TCR&#8208;triggered stimulation of the hybridomas was quantified using a chromogenic substrate: chlorophenol red&#8208;&#946;&#8208;D&#8208;galactopyranoside (CPRG, Roche). Cleavage of CPRG by &#946;&#8208;galactosidase releases a purple product, which absorbance was read at 595&#160;nm with a reference at 650&#160;nm.</p></sec><sec id="emmm201708123-sec-0017"><title>
<italic>Ex vivo</italic> spleen T&#8208;cell restimulations</title><p>Spleens from infected mice were collected, mashed on a 70&#8208;&#956;m cell strainer in RPMI supplemented with 10% of FBS and treated with RBC lysis buffer (ACK: 100&#160;&#956;M EDTA, 160&#160;mM NH<sub>4</sub>Cl, and 10&#160;mM NaHCO<sub>3</sub>). 10<sup>6</sup> spleen cells were incubated for 5&#160;h at 37&#176;C in the presence of brefeldin A with 10<sup>5</sup> DC with or without 5&#160;&#956;M of peptide, or with pRBC&#8208;loaded DC. Intracellular IFN&#947; (IFN&#947;&#8208;APC, XMG1.2 1/500 BD Pharmingen), TNF (TNF&#8208;AF700, MP6&#8208;XT22 1/300 BD Pharmingen), and IL&#8208;10 (IL10&#8208;BV650, JES5&#8208;16E3 1/300 BD Horizon) were detected with Cytofix/Cytoperm kit (BD Pharmingen) or Intracellular Fixation and Permeabilization Buffer Set (eBioscience). In addition to the newly identified <italic>Pb</italic>A peptides, we used the following control peptides: OVA/IR17 (ISQAVHAAHAEINEAGR) and <italic>T.&#160;gondii</italic> AS15 (AVEIHRPVPGTAPPS) restricted by I&#8208;A<sup>b</sup>, F4 (EIYIFTNI; Lau <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0045" ref-type="ref">2011</xref>), and GAP50 (SQLLNAKYL; Howland <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0038" ref-type="ref">2013</xref>) restricted by K<sup>b</sup> and D<sup>b,</sup> respectively.</p></sec><sec id="emmm201708123-sec-0018"><title>Analysis and <italic>ex&#160;vivo</italic> isolation of spleen APC subsets</title><p>Spleens were perfused with collagenase D (1&#160;mg/ml) and DNAse I (0.1&#160;mg/ml), cut into small pieces and incubated at 37&#176;C for 45&#160;min. Cell preparations were filtered using 100&#8208;&#956;M cell strainers, and APC populations were enriched using magnetic depletion of B, NK, and T cells (Miltenyi). For experiments that focused only on cDC, cDC were enriched using CD11c&#8208;positive selection (Miltenyi). Cell suspensions were labeled with the following antibodies: CD3&#8208;APC (145&#8208;2C11, 1/300 eBioscience), CD19&#8208;APC (ID3, 1/300 Biolegend), NK1.1&#8208;APC (PK136, 1/300 BD Pharmingen), B220&#8208;BV510 (RA3&#8208;6B2, 1/500, BD Horizon), CD11b PE&#8208;CF594 (M1/70, 1/3000 BD Horizon), CD11c PE&#8208;Cy7 (HL3, 1/400 BD Pharmingen), Ly6C&#8208;PerCP&#8208;Cy5.5 (AL&#8208;21, 1/1000 BD Pharmingen), CD64 BV421 (X54&#8208;5/7.1, 1/300 Biolegend), CD8&#945; APC&#8208;Cy7 (53&#8208;6.7, 1/200 BD Pharmingen), or XCR1&#8208;PE (REA707, 1/100 Miltenyi). Cells were sorted on a BD AriaSorp (BD Biosciences) with purity routinely higher than 95%. Expression of MHC II was assessed in a separate mix since the anti&#8208;I&#8208;A<sup>b</sup> AF700 (M5/114, 1/500 BD Pharmingen) is a blocking antibody. For experiments with <italic>Karma</italic> mice in which cDC1 are Tomato<sup>+</sup>, CD11b&#8208;PerCP&#8208;Cy5 (M1/70, 1/200 BD Pharmingen) was used. All flow cytometry samples were run on a Fortessa (BD Biosciences) and analyzed using FlowJo software.</p></sec><sec id="emmm201708123-sec-0019"><title>
<italic>Ex vivo</italic> antigen presentation assays</title><p>FACS&#8208;sorted APC were serially diluted into 96&#8208;W round&#8208;bottom plates and mixed with 10<sup>5</sup> T&#8208;cell hybrids/well. For non&#8208;<italic>Pb</italic>A antigens, 5&#160;&#215;&#160;10<sup>4</sup> FACS&#8208;sorted DC per well were seeded in a 96&#8208;W round&#8208;bottom plate and treated as follows. To readout presentation of heat&#8208;killed <italic>T.&#160;gondii</italic>, RH tachyzoites were treated for 15 min at 56&#176;C in PBS and incubated with DC for 3 h before adding BTg01Z hybrids (Grover <italic>et&#160;al</italic>, <xref rid="emmm201708123-bib-0029" ref-type="ref">2012</xref>). To readout presentation of OVA&#8208;expressing <italic>E.&#160;coli</italic>, an overnight pre&#8208;culture of DH5&#945; transformed with pGEX.4T1.OVA was transferred to 7&#160;ml of LB medium containing 100&#160;&#956;g/ml ampicillin and grown for 1&#160;h. IPTG was added, and bacteria were grown for 4 more hours at 30&#176;C. Bacteria were counted, washed, suspended in antibiotic&#8208;free serum&#8208;free RPMI, and incubated with DC at the indicated MOI for 40&#160;min. After washing, gentamycin (100&#160;&#956;g/ml) was added for 3 h followed by incubation with 10<sup>5</sup> OTIIZ/well (Sahara &amp; Shastri, <xref rid="emmm201708123-bib-0071" ref-type="ref">2003</xref>). For exogenous peptide loading, the <italic>T.&#160;gondii</italic> I&#8208;A<sup>b</sup> peptide (AS15) was added to the DC simultaneously with the BTg01Z hybrids.</p></sec><sec id="emmm201708123-sec-0020"><title>Statistical analyses</title><p>The Prism software (GraphPad) was used for statistical analyses. To compare each peptide to the OVA peptide in <italic>ex&#160;vivo</italic> restimulation assays, nonparametric paired <italic>t</italic>&#8208;tests (Wilcoxon) were used. For other comparisons, unpaired <italic>t</italic>&#8208;tests without assuming consistent SD (Welch's correction) were used.</p></sec><sec id="emmm201708123-sec-0021"><title>Data deposition</title><p>The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD007628.</p></sec></sec><sec id="emmm201708123-sec-0023"><title>Author contributions</title><p>Conceived and designed the experiments: MDr, MFW, J&#8208;MS, TDA, ST, JS, ASe, AB, OS, NB. Performed the experiments: MDr, MFW, J&#8208;MS, TDA, AH, ASa, JS. Provided <italic>Karma</italic> mice and helped design the related experiments: KC, MDa. Provided mice immunized with <italic>Pb</italic> NK65 &#916;HRF: CD&#8208;G. Wrote the manuscript: NB with help of coauthors.</p></sec><sec id="emmm201708123-sec-0024"><title>Conflict of interest</title><p>The authors declare that they have no conflict of interest.</p></sec><sec id="emmm201708123-sec-0025"><boxed-text position="float" content-type="box" id="emmm201708123-blk-0001" orientation="portrait"><caption><title>The paper explained</title></caption><sec id="emmm201708123-sec-0026"><title>Problem</title><p>Malaria is a parasitic disease causing life&#8208;threatening complications like cerebral malaria. Natural protective immunity takes years to develop, and the efficacy of currently developed vaccines is limited. During malaria, the immune cross talk between dendritic cells (DC) and T cells prompts CD4 T cells to differentiate into functionally distinct subsets, which control the fate of memory CD8 T cell and antibody responses and ultimately determine the balance between parasite control and immunopathology. A major aim is to improve protective immunity without exacerbating immunopathology. To do this, one needs to elucidate how DC control the functionality of parasite&#8208;specific CD4 T cells.</p></sec><sec id="emmm201708123-sec-0027"><title>Results</title><p>We work with a mouse malaria model induced by <italic>Plasmodium berghei</italic>. We use proteomics to identify parasite MHC class II antigens that elicit CD4 T cells in infected mice, as well as in long&#8208;term protected mice vaccinated with an attenuated parasite. We find that a peculiar DC subset, named cDC1, is superior for MHC II presentation of <italic>Plasmodium</italic>&#8208;derived antigens. We further show that cDC1 promote the differentiation of a type of parasite&#8208;specific CD4 T cells that play a pathogenic role in cerebral malaria (Th1) and that they inhibit the development of regulatory IL&#8208;10<sup>+</sup> CD4 T cells.</p></sec><sec id="emmm201708123-sec-0028"><title>Impact</title><p>Our work sets the stage for MHC II immunopeptidome profiling in blood&#8208;stage human malaria. This should help uncover new vaccine targets and down&#8208;select vaccine candidates. Our study also supports the idea of harnessing DC functions to curtail excessive Th1 responses in human severe malaria.</p></sec></boxed-text></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material content-type="local-data"/><supplementary-material content-type="local-data" id="emmm201708123-sup-0001"><caption><p>Expanded View Figures PDF</p></caption><media xlink:href="EMMM-9-1605-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="emmm201708123-sup-0002"><caption><p>Dataset EV1</p></caption><media xlink:href="EMMM-9-1605-s002.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="emmm201708123-sup-0003"><caption><p>Dataset EV2</p></caption><media xlink:href="EMMM-9-1605-s003.xlsx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data"><caption><p>Review Process File</p></caption><media xlink:href="EMMM-9-1605-s004.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="emmm201708123-sec-0022"><title>Acknowledgements</title><p>F. L'Faqihi&#8208;Olive, V. Duplan&#8208;Eche, A.&#8208;L. Iscache, and P. Menut for technical assistance at the CPTP&#8208;INSERM U1043 flow cytometry facility, R. Balouzat and the zootechnicians at INSERM UMS006&#8208;CREFRE mouse facility, J.F. Franetich, M. Tefit, and T. Houpert for mosquito breeding, E. Bassot and F. de Giorgi for technical help, the Blanchard team for helpful discussions, H. Acha&#8208;Orbea for the MutuDC, M. Rescigno for the <italic>E.&#160;coli</italic>&#8208;OVA, A.&#8208;M. Lennon&#8208;Dum&#233;nil and D. Lankar for the JV2 antibody. This work was supported by Human Frontier Science Program Organization (CDA00047/2011 to NB), PIA PARAFRAP Consortium (ANR&#8208;11&#8208;LABX0024 to NB and OS), PIA ANINFIMIP equipment (ANR&#8208;11&#8208;EQPX&#8208;0003 to NB), R&#233;gion Occitanie PhD co&#8208;funding (MD), &#8220;Minist&#232;re de l'Education Nationale, de la Recherche et de la Technologie&#8221; (AH), Idex Toulouse &#8220;Attractivity Chair&#8221; Program (NB).</p></ack><ref-list content-type="cited-references" id="emmm201708123-bibl-0001"><title>References</title><ref id="emmm201708123-bib-0001"><mixed-citation publication-type="journal" id="emmm201708123-cit-0001">
<string-name>
<surname>Alexandre</surname>
<given-names>YO</given-names>
</string-name>, <string-name>
<surname>Ghilas</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Sanchez</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Le Bon</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Crozat</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Dalod</surname>
<given-names>M</given-names>
</string-name> (<year>2016</year>) <article-title>XCR1<sup>+</sup> dendritic cells promote memory CD8<sup>+</sup> T cell recall upon secondary infections with <italic>Listeria monocytogenes</italic> or certain viruses</article-title>. <source>J Exp Med</source>
<volume>213</volume>: <fpage>75</fpage>&#8211;<lpage>92</lpage>
<pub-id pub-id-type="pmid">26694969</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0002"><mixed-citation publication-type="journal" id="emmm201708123-cit-0002">
<string-name>
<surname>Argiro</surname>
<given-names>LL</given-names>
</string-name>, <string-name>
<surname>Kohlstadt</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Henri</surname>
<given-names>SS</given-names>
</string-name>, <string-name>
<surname>Dessein</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Matabiau</surname>
<given-names>VV</given-names>
</string-name>, <string-name>
<surname>Paris</surname>
<given-names>PP</given-names>
</string-name>, <string-name>
<surname>Bourgois</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Dessein</surname>
<given-names>AJ</given-names>
</string-name> (<year>2000</year>) <article-title>Identification of a candidate vaccine peptide on the 37 kDa Schistosoma mansoni GAPDH</article-title>. <source>Vaccine</source>
<volume>18</volume>: <fpage>2039</fpage>&#8211;<lpage>2048</lpage>
<pub-id pub-id-type="pmid">10706967</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0003"><mixed-citation publication-type="journal" id="emmm201708123-cit-0003">
<string-name>
<surname>Ashok</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Schuster</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ronet</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rosa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Mack</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Lavanchy</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Marraco</surname>
<given-names>SF</given-names>
</string-name>, <string-name>
<surname>Fasel</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>KM</given-names>
</string-name>, <string-name>
<surname>Tacchini&#8208;Cottier</surname>
<given-names>F</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2014</year>) <article-title>Cross&#8208;presenting dendritic cells are required for control of Leishmania major infection</article-title>. <source>Eur J Immunol</source>
<volume>44</volume>: <fpage>1422</fpage>&#8211;<lpage>1432</lpage>
<pub-id pub-id-type="pmid">24643576</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0004"><mixed-citation publication-type="journal" id="emmm201708123-cit-0004">
<string-name>
<surname>Audiger</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Rahman</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Yun</surname>
<given-names>TJ</given-names>
</string-name>, <string-name>
<surname>Tarbell</surname>
<given-names>KV</given-names>
</string-name>, <string-name>
<surname>Lesage</surname>
<given-names>S</given-names>
</string-name> (<year>2017</year>) <article-title>The importance of dendritic cells in maintaining immune tolerance</article-title>. <source>J Immunol</source>
<volume>198</volume>: <fpage>2223</fpage>&#8211;<lpage>2231</lpage>
<pub-id pub-id-type="pmid">28264998</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0005"><mixed-citation publication-type="journal" id="emmm201708123-cit-0005">
<string-name>
<surname>Backer</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>van Leeuwen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Kraal</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>den Haan</surname>
<given-names>JM</given-names>
</string-name> (<year>2008</year>) <article-title>CD8&#8208; dendritic cells preferentially cross&#8208;present Saccharomyces cerevisiae antigens</article-title>. <source>Eur J Immunol</source>
<volume>38</volume>: <fpage>370</fpage>&#8211;<lpage>380</lpage>
<pub-id pub-id-type="pmid">18200498</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0006"><mixed-citation publication-type="journal" id="emmm201708123-cit-0006">
<string-name>
<surname>Belnoue</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kayibanda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Vigario</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Deschemin</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>van Rooijen</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Viguier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Snounou</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name> (<year>2002</year>) <article-title>On the pathogenic role of brain&#8208;sequestered alphabeta CD8+ T cells in experimental cerebral malaria</article-title>. <source>J Immunol</source>
<volume>169</volume>: <fpage>6369</fpage>&#8211;<lpage>6375</lpage>
<pub-id pub-id-type="pmid">12444144</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0007"><mixed-citation publication-type="journal" id="emmm201708123-cit-0007">
<string-name>
<surname>Bozzacco</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Zebroski</surname>
<given-names>HA</given-names>
</string-name>, <string-name>
<surname>Dengjel</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Deng</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Mojsov</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Steinman</surname>
<given-names>RM</given-names>
</string-name> (<year>2011</year>) <article-title>Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells</article-title>. <source>J Proteome Res</source>
<volume>10</volume>: <fpage>5016</fpage>&#8211;<lpage>5030</lpage>
<pub-id pub-id-type="pmid">21913724</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0008"><mixed-citation publication-type="journal" id="emmm201708123-cit-0008">
<string-name>
<surname>Bozzacco</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Yu</surname>
<given-names>H</given-names>
</string-name> (<year>2013</year>) <article-title>Identification and quantitation of MHC class II&#8208;bound peptides from mouse spleen dendritic cells by immunoprecipitation and mass spectrometry analysis</article-title>. <source>Methods Mol Biol</source>
<volume>1061</volume>: <fpage>231</fpage>&#8211;<lpage>243</lpage>
<pub-id pub-id-type="pmid">23963941</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0009"><mixed-citation publication-type="journal" id="emmm201708123-cit-0009">
<string-name>
<surname>Calabro</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Gallman</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gowthaman</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Krishnaswamy</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Nascimento</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Patel</surname>
<given-names>SR</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2016</year>) <article-title>Bridging channel dendritic cells induce immunity to transfused red blood cells</article-title>. <source>J Exp Med</source>
<volume>213</volume>: <fpage>887</fpage>&#8211;<lpage>896</lpage>
<pub-id pub-id-type="pmid">27185856</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0010"><mixed-citation publication-type="journal" id="emmm201708123-cit-0010">
<string-name>
<surname>Campanella</surname>
<given-names>GS</given-names>
</string-name>, <string-name>
<surname>Tager</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>El Khoury</surname>
<given-names>JK</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Abrazinski</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Manice</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Colvin</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Luster</surname>
<given-names>AD</given-names>
</string-name> (<year>2008</year>) <article-title>Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>105</volume>: <fpage>4814</fpage>&#8211;<lpage>4819</lpage>
<pub-id pub-id-type="pmid">18347328</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0011"><mixed-citation publication-type="journal" id="emmm201708123-cit-0011">
<string-name>
<surname>Caron</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Kowalewski</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Chiek Koh</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sturm</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Schuster</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Aebersold</surname>
<given-names>R</given-names>
</string-name> (<year>2015</year>) <article-title>Analysis of major histocompatibility complex (MHC) immunopeptidomes using mass spectrometry</article-title>. <source>Mol Cell Proteomics</source>
<volume>14</volume>: <fpage>3105</fpage>&#8211;<lpage>3117</lpage>
<pub-id pub-id-type="pmid">26628741</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0012"><mixed-citation publication-type="journal" id="emmm201708123-cit-0012">
<string-name>
<surname>Cha</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Kim</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Pandey</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Jacobs&#8208;Lorena</surname>
<given-names>M</given-names>
</string-name> (<year>2016</year>) <article-title>Identification of GAPDH on the surface of Plasmodium sporozoites as a new candidate for targeting malaria liver invasion</article-title>. <source>J Exp Med</source>
<volume>213</volume>: <fpage>2099</fpage>&#8211;<lpage>2112</lpage>
<pub-id pub-id-type="pmid">27551151</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0013"><mixed-citation publication-type="journal" id="emmm201708123-cit-0013">
<string-name>
<surname>Chen</surname>
<given-names>JH</given-names>
</string-name>, <string-name>
<surname>Chen</surname>
<given-names>SB</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Ju</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhang</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Xu</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shen</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Mo</surname>
<given-names>XJ</given-names>
</string-name>, <string-name>
<surname>Molina</surname>
<given-names>DM</given-names>
</string-name>, <string-name>
<surname>Eng</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2015</year>) <article-title>An immunomics approach for the analysis of natural antibody responses to Plasmodium vivax infection</article-title>. <source>Mol BioSyst</source>
<volume>11</volume>: <fpage>2354</fpage>&#8211;<lpage>2363</lpage>
<pub-id pub-id-type="pmid">26091354</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0014"><mixed-citation publication-type="journal" id="emmm201708123-cit-0014">
<string-name>
<surname>Claser</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>De Souza</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Thorburn</surname>
<given-names>SG</given-names>
</string-name>, <string-name>
<surname>Grau</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Hafalla</surname>
<given-names>JCR</given-names>
</string-name> (<year>2017</year>) <article-title>Host resistance to plasmodium&#8208;induced acute immune pathology is regulated by interleukin&#8208;10 receptor signaling</article-title>. <source>Infect Immun</source>
<volume>85</volume>: <fpage>e00941&#8208;16</fpage>
<pub-id pub-id-type="pmid">28396319</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0015"><mixed-citation publication-type="journal" id="emmm201708123-cit-0015">
<string-name>
<surname>Cockburn</surname>
<given-names>IA</given-names>
</string-name>, <string-name>
<surname>Zavala</surname>
<given-names>F</given-names>
</string-name> (<year>2016</year>) <article-title>Dendritic cell function and antigen presentation in malaria</article-title>. <source>Curr Opin Immunol</source>
<volume>40</volume>: <fpage>1</fpage>&#8211;<lpage>6</lpage>
<pub-id pub-id-type="pmid">26845735</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0016"><mixed-citation publication-type="journal" id="emmm201708123-cit-0016">
<string-name>
<surname>Couper</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Blount</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Hafalla</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Belkaid</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Kamanaka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Flavell</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>de Souza</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>EM</given-names>
</string-name> (<year>2008</year>) <article-title>IL&#8208;10 from CD4CD25Foxp3CD127 adaptive regulatory T cells modulates parasite clearance and pathology during malaria infection</article-title>. <source>PLoS Pathog</source>
<volume>4</volume>: <fpage>e1000004</fpage>
<pub-id pub-id-type="pmid">18401464</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0017"><mixed-citation publication-type="journal" id="emmm201708123-cit-0017">
<string-name>
<surname>Daubenberger</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Tisdale</surname>
<given-names>EJ</given-names>
</string-name>, <string-name>
<surname>Curcic</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Diaz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Silvie</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Mazier</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Eling</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Bohrmann</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Matile</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Pluschke</surname>
<given-names>G</given-names>
</string-name> (<year>2003</year>) <article-title>The N&#8217;&#8208;terminal domain of glyceraldehyde&#8208;3&#8208;phosphate dehydrogenase of the apicomplexan Plasmodium falciparum mediates GTPase Rab2&#8208;dependent recruitment to membranes</article-title>. <source>Biol Chem</source>
<volume>384</volume>: <fpage>1227</fpage>&#8211;<lpage>1237</lpage>
<pub-id pub-id-type="pmid">12974391</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0018"><mixed-citation publication-type="journal" id="emmm201708123-cit-0018">
<string-name>
<surname>Demarta&#8208;Gatsi</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Thiberge</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Peronet</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Commere</surname>
<given-names>PH</given-names>
</string-name>, <string-name>
<surname>Matondo</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Apetoh</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Bruhns</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Menard</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Mecheri</surname>
<given-names>S</given-names>
</string-name> (<year>2016</year>) <article-title>Protection against malaria in mice is induced by blood stage&#8208;arresting histamine&#8208;releasing factor (HRF)&#8208;deficient parasites</article-title>. <source>J Exp Med</source>
<volume>213</volume>: <fpage>1419</fpage>&#8211;<lpage>1428</lpage>
<pub-id pub-id-type="pmid">27432939</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0019"><mixed-citation publication-type="journal" id="emmm201708123-cit-0019">
<string-name>
<surname>Dudziak</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Kamphorst</surname>
<given-names>AO</given-names>
</string-name>, <string-name>
<surname>Heidkamp</surname>
<given-names>GF</given-names>
</string-name>, <string-name>
<surname>Buchholz</surname>
<given-names>VR</given-names>
</string-name>, <string-name>
<surname>Trumpfheller</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Yamazaki</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Cheong</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Liu</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Lee</surname>
<given-names>HW</given-names>
</string-name>, <string-name>
<surname>Park</surname>
<given-names>CG</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2007</year>) <article-title>Differential antigen processing by dendritic cell subsets <italic>in&#160;vivo</italic>
</article-title>. <source>Science</source>
<volume>315</volume>: <fpage>107</fpage>&#8211;<lpage>111</lpage>
<pub-id pub-id-type="pmid">17204652</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0020"><mixed-citation publication-type="journal" id="emmm201708123-cit-0020">
<string-name>
<surname>Durai</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>KM</given-names>
</string-name> (<year>2016</year>) <article-title>Functions of murine dendritic cells</article-title>. <source>Immunity</source>
<volume>45</volume>: <fpage>719</fpage>&#8211;<lpage>736</lpage>
<pub-id pub-id-type="pmid">27760337</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0021"><mixed-citation publication-type="journal" id="emmm201708123-cit-0021">
<string-name>
<surname>Dutertre</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>LF</given-names>
</string-name>, <string-name>
<surname>Ginhoux</surname>
<given-names>F</given-names>
</string-name> (<year>2014</year>) <article-title>Aligning bona fide dendritic cell populations across species</article-title>. <source>Cell Immunol</source>
<volume>291</volume>: <fpage>3</fpage>&#8211;<lpage>10</lpage>
<pub-id pub-id-type="pmid">25262488</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0022"><mixed-citation publication-type="journal" id="emmm201708123-cit-0022">
<string-name>
<surname>Eickhoff</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Brewitz</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gerner</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Klauschen</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Komander</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hemmi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Garbi</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kaisho</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Germain</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Kastenmuller</surname>
<given-names>W</given-names>
</string-name> (<year>2015</year>) <article-title>Robust anti&#8208;viral immunity requires multiple distinct T cell&#8208;dendritic cell interactions</article-title>. <source>Cell</source>
<volume>162</volume>: <fpage>1322</fpage>&#8211;<lpage>1337</lpage>
<pub-id pub-id-type="pmid">26296422</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0023"><mixed-citation publication-type="journal" id="emmm201708123-cit-0023">
<string-name>
<surname>Fauconnier</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Palomo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Bourigault</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Meme</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Szeremeta</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Beloeil</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Danneels</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Charron</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rihet</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Ryffel</surname>
<given-names>B</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2012</year>) <article-title>IL&#8208;12Rbeta2 is essential for the development of experimental cerebral malaria</article-title>. <source>J Immunol</source>
<volume>188</volume>: <fpage>1905</fpage>&#8211;<lpage>1914</lpage>
<pub-id pub-id-type="pmid">22238458</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0024"><mixed-citation publication-type="journal" id="emmm201708123-cit-0024">
<string-name>
<surname>Feliu</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Vasseur</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Grover</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Chu</surname>
<given-names>HH</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Wang</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Boyle</surname>
<given-names>JP</given-names>
</string-name>, <string-name>
<surname>Robey</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Shastri</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Blanchard</surname>
<given-names>N</given-names>
</string-name> (<year>2013</year>) <article-title>Location of the CD8 T cell epitope within the antigenic precursor determines immunogenicity and protection against the <italic>Toxoplasma gondii</italic> parasite</article-title>. <source>PLoS Pathog</source>
<volume>9</volume>: <fpage>e1003449</fpage>
<pub-id pub-id-type="pmid">23818852</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0200"><mixed-citation publication-type="journal" id="emmm201708123-cit-0200">
<string-name>
<surname>Fernandez&#8208;Ruiz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Ghazanfari</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>WY</given-names>
</string-name>, <string-name>
<surname>Davey</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Berthold</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Holz</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Kato</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Bayarsaikhan</surname>
<given-names>G</given-names>
</string-name>
<italic>et al</italic> (<year>2017</year>) <article-title>Development of a novel CD4<sup>+</sup> TCR transgenic line that reveals a dominant role for CD8<sup>+</sup> DC and CD40&#8208;signaling in the generation of helper and CTL responses to blood stage malaria</article-title>. <source>bioRxiv</source>
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/113837">https://doi.org/10.1101/113837</ext-link>
</mixed-citation></ref><ref id="emmm201708123-bib-0025"><mixed-citation publication-type="journal" id="emmm201708123-cit-0025">
<string-name>
<surname>Freitas do Rosario</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Lamb</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Spence</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Stephens</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Lang</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Roers</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Muller</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>O'Garra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Langhorne</surname>
<given-names>J</given-names>
</string-name> (<year>2012</year>) <article-title>IL&#8208;27 promotes IL&#8208;10 production by effector Th1 CD4<sup>+</sup> T cells: a critical mechanism for protection from severe&#160;immunopathology during malaria infection</article-title>. <source>J Immunol</source>
<volume>188</volume>: <fpage>1178</fpage>&#8211;<lpage>1190</lpage>.<pub-id pub-id-type="pmid">22205023</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0026"><mixed-citation publication-type="journal" id="emmm201708123-cit-0026">
<string-name>
<surname>Freitas do Rosario</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Langhorne</surname>
<given-names>J</given-names>
</string-name> (<year>2012</year>) <article-title>T cell&#8208;derived IL&#8208;10 and its impact on the regulation of host responses during malaria</article-title>. <source>Int J Parasitol</source>
<volume>42</volume>: <fpage>549</fpage>&#8211;<lpage>555</lpage>.<pub-id pub-id-type="pmid">22549022</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0027"><mixed-citation publication-type="journal" id="emmm201708123-cit-0027">
<string-name>
<surname>Frevert</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Krzych</surname>
<given-names>U</given-names>
</string-name> (<year>2015</year>) <article-title>Plasmodium cellular effector mechanisms and the hepatic microenvironment</article-title>. <source>Front Microbiol</source>
<volume>6</volume>: <fpage>482</fpage>
<pub-id pub-id-type="pmid">26074888</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0028"><mixed-citation publication-type="journal" id="emmm201708123-cit-0028">
<string-name>
<surname>Fuertes Marraco</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Grosjean</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Duval</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Rosa</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Lavanchy</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Ashok</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Haller</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Otten</surname>
<given-names>LA</given-names>
</string-name>, <string-name>
<surname>Steiner</surname>
<given-names>QG</given-names>
</string-name>, <string-name>
<surname>Descombes</surname>
<given-names>P</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2012</year>) <article-title>Novel murine dendritic cell lines: a powerful auxiliary tool for dendritic cell research</article-title>. <source>Front Immunol</source>
<volume>3</volume>: <fpage>331</fpage>
<pub-id pub-id-type="pmid">23162549</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0029"><mixed-citation publication-type="journal" id="emmm201708123-cit-0029">
<string-name>
<surname>Grover</surname>
<given-names>HS</given-names>
</string-name>, <string-name>
<surname>Blanchard</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Gonzalez</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Chan</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Robey</surname>
<given-names>EA</given-names>
</string-name>, <string-name>
<surname>Shastri</surname>
<given-names>N</given-names>
</string-name> (<year>2012</year>) <article-title>The <italic>Toxoplasma gondii</italic> peptide AS15 elicits CD4 T cells that can control parasite burden</article-title>. <source>Infect Immun</source>
<volume>80</volume>: <fpage>3279</fpage>&#8211;<lpage>3288</lpage>
<pub-id pub-id-type="pmid">22778097</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0030"><mixed-citation publication-type="journal" id="emmm201708123-cit-0030">
<string-name>
<surname>Guilliams</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ginhoux</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Jakubzick</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Naik</surname>
<given-names>SH</given-names>
</string-name>, <string-name>
<surname>Onai</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Schraml</surname>
<given-names>BU</given-names>
</string-name>, <string-name>
<surname>Segura</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Tussiwand</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Yona</surname>
<given-names>S</given-names>
</string-name> (<year>2014</year>) <article-title>Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny</article-title>. <source>Nat Rev Immunol</source>
<volume>14</volume>: <fpage>571</fpage>&#8211;<lpage>578</lpage>
<pub-id pub-id-type="pmid">25033907</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0031"><mixed-citation publication-type="journal" id="emmm201708123-cit-0031">
<string-name>
<surname>Hafalla</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Claser</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Couper</surname>
<given-names>KN</given-names>
</string-name>, <string-name>
<surname>Grau</surname>
<given-names>GE</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>de Souza</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>EM</given-names>
</string-name> (<year>2012</year>) <article-title>The CTLA&#8208;4 and PD&#8208;1/PD&#8208;L1 inhibitory pathways independently regulate host resistance to plasmodium&#8208;induced acute immune pathology</article-title>. <source>PLoS Pathog</source>
<volume>8</volume>: <fpage>e1002504</fpage>
<pub-id pub-id-type="pmid">22319445</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0032"><mixed-citation publication-type="journal" id="emmm201708123-cit-0032">
<string-name>
<surname>Hansen</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Obeng&#8208;Adjei</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ly</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ioannidis</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Crompton</surname>
<given-names>PD</given-names>
</string-name> (<year>2017</year>) <article-title>Emerging concepts in T follicular helper cell responses to malaria</article-title>. <source>Int J Parasitol</source>
<volume>47</volume>: <fpage>105</fpage>&#8211;<lpage>110</lpage>
<pub-id pub-id-type="pmid">27866903</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0033"><mixed-citation publication-type="journal" id="emmm201708123-cit-0033">
<string-name>
<surname>Haque</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Best</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Montes de Oca</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Ammerdorffer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Edwards</surname>
<given-names>CL</given-names>
</string-name>, <string-name>
<surname>de Labastida Rivera</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Amante</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Bunn</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Sheel</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2014</year>) <article-title>Type I IFN signaling in CD8&#8208; DCs impairs Th1&#8208;dependent malaria immunity</article-title>. <source>J Clin Invest</source>
<volume>124</volume>: <fpage>2483</fpage>&#8211;<lpage>2496</lpage>
<pub-id pub-id-type="pmid">24789914</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0034"><mixed-citation publication-type="journal" id="emmm201708123-cit-0034">
<string-name>
<surname>Helft</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Manicassamy</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Guermonprez</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Hashimoto</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Silvin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Agudo</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Brown</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Schmolke</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Miller</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Leboeuf</surname>
<given-names>M</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2012</year>) <article-title>Cross&#8208;presenting CD103<sup>+</sup> dendritic cells are protected from influenza virus infection</article-title>. <source>J Clin Invest</source>
<volume>122</volume>: <fpage>4037</fpage>&#8211;<lpage>4047</lpage>
<pub-id pub-id-type="pmid">23041628</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0035"><mixed-citation publication-type="journal" id="emmm201708123-cit-0035">
<string-name>
<surname>Heyder</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Kohler</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Tarasova</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Haag</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Rutishauser</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Rivera</surname>
<given-names>NV</given-names>
</string-name>, <string-name>
<surname>Sandin</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Mia</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Malmstrom</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Wheelock</surname>
<given-names>AM</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2016</year>) <article-title>Approach for identifying human leukocyte antigen (HLA)&#8208;DR bound peptides from scarce clinical samples</article-title>. <source>Mol Cell Proteomics</source>
<volume>15</volume>: <fpage>3017</fpage>&#8211;<lpage>3029</lpage>
<pub-id pub-id-type="pmid">27452731</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0036"><mixed-citation publication-type="journal" id="emmm201708123-cit-0036">
<string-name>
<surname>Hildner</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Edelson</surname>
<given-names>BT</given-names>
</string-name>, <string-name>
<surname>Purtha</surname>
<given-names>WE</given-names>
</string-name>, <string-name>
<surname>Diamond</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Matsushita</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Kohyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Calderon</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Schraml</surname>
<given-names>BU</given-names>
</string-name>, <string-name>
<surname>Unanue</surname>
<given-names>ER</given-names>
</string-name>, <string-name>
<surname>Diamond</surname>
<given-names>MS</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2008</year>) <article-title>Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity</article-title>. <source>Science</source>
<volume>322</volume>: <fpage>1097</fpage>&#8211;<lpage>1100</lpage>
<pub-id pub-id-type="pmid">19008445</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0037"><mixed-citation publication-type="journal" id="emmm201708123-cit-0037">
<string-name>
<surname>Hor</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Whitney</surname>
<given-names>PG</given-names>
</string-name>, <string-name>
<surname>Zaid</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Heath</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Mueller</surname>
<given-names>SN</given-names>
</string-name> (<year>2015</year>) <article-title>Spatiotemporally distinct interactions with dendritic cell subsets facilitates CD4<sup>+</sup> and CD8<sup>+</sup> T cell activation to localized viral infection</article-title>. <source>Immunity</source>
<volume>43</volume>: <fpage>554</fpage>&#8211;<lpage>565</lpage>
<pub-id pub-id-type="pmid">26297566</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0038"><mixed-citation publication-type="journal" id="emmm201708123-cit-0038">
<string-name>
<surname>Howland</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Poh</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Gun</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Claser</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Malleret</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Shastri</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Ginhoux</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Grotenbreg</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name> (<year>2013</year>) <article-title>Brain microvessel cross&#8208;presentation is a hallmark of experimental cerebral malaria</article-title>. <source>EMBO Mol Med</source>
<volume>5</volume>: <fpage>984</fpage>&#8211;<lpage>999</lpage>
<pub-id pub-id-type="pmid">23681698</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0039"><mixed-citation publication-type="journal" id="emmm201708123-cit-0039">
<string-name>
<surname>Howland</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Claser</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Poh</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Gun</surname>
<given-names>SY</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name> (<year>2015a</year>) <article-title>Pathogenic CD8+ T cells in experimental cerebral malaria</article-title>. <source>Semin Immunopathol</source>
<volume>37</volume>: <fpage>221</fpage>&#8211;<lpage>231</lpage>
<pub-id pub-id-type="pmid">25772948</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0040"><mixed-citation publication-type="journal" id="emmm201708123-cit-0040">
<string-name>
<surname>Howland</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Poh</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name> (<year>2015b</year>) <article-title>Activated brain endothelial cells cross&#8208;present malaria antigen</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>: <fpage>e1004963</fpage>
<pub-id pub-id-type="pmid">26046849</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0041"><mixed-citation publication-type="journal" id="emmm201708123-cit-0041">
<string-name>
<surname>Imai</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Ishida</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Suzue</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hirai</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Taniguchi</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Okada</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Suzuki</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Shimokawa</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Hisaeda</surname>
<given-names>H</given-names>
</string-name> (<year>2013</year>) <article-title>CD8(+) T cell activation by murine erythroblasts infected with malaria parasites</article-title>. <source>Sci Rep</source>
<volume>3</volume>: <fpage>1572</fpage>
<pub-id pub-id-type="pmid">23535896</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0042"><mixed-citation publication-type="journal" id="emmm201708123-cit-0042">
<string-name>
<surname>Janssen</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Droin</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Lemmens</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Pinkoski</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Bensinger</surname>
<given-names>SJ</given-names>
</string-name>, <string-name>
<surname>Ehst</surname>
<given-names>BD</given-names>
</string-name>, <string-name>
<surname>Griffith</surname>
<given-names>TS</given-names>
</string-name>, <string-name>
<surname>Green</surname>
<given-names>DR</given-names>
</string-name>, <string-name>
<surname>Schoenberger</surname>
<given-names>SP</given-names>
</string-name> (<year>2005</year>) <article-title>CD4+ T&#8208;cell help controls CD8+ T&#8208;cell memory via TRAIL&#8208;mediated activation&#8208;induced cell death</article-title>. <source>Nature</source>
<volume>434</volume>: <fpage>88</fpage>&#8211;<lpage>93</lpage>
<pub-id pub-id-type="pmid">15744305</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0043"><mixed-citation publication-type="journal" id="emmm201708123-cit-0043">
<string-name>
<surname>Jin</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Agarwal</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Pancholi</surname>
<given-names>V</given-names>
</string-name> (<year>2011</year>) <article-title>Surface export of GAPDH/SDH, a glycolytic enzyme, is essential for Streptococcus pyogenes virulence</article-title>. <source>MBio</source>
<volume>2</volume>: <fpage>e00068&#8208;00011</fpage>
<pub-id pub-id-type="pmid">21628503</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0044"><mixed-citation publication-type="journal" id="emmm201708123-cit-0044">
<string-name>
<surname>Kimura</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Miyakoda</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kimura</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Honma</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Hara</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yoshida</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Yui</surname>
<given-names>K</given-names>
</string-name> (<year>2016</year>) <article-title>Interleukin&#8208;27&#8208;producing CD4(+) T cells regulate protective immunity during malaria parasite infection</article-title>. <source>Immunity</source>
<volume>44</volume>: <fpage>672</fpage>&#8211;<lpage>682</lpage>
<pub-id pub-id-type="pmid">26968425</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0045"><mixed-citation publication-type="journal" id="emmm201708123-cit-0045">
<string-name>
<surname>Lau</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Fernandez Ruiz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Davey</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>de Koning&#8208;Ward</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Papenfuss</surname>
<given-names>AT</given-names>
</string-name>, <string-name>
<surname>Carbone</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Brooks</surname>
<given-names>AG</given-names>
</string-name>, <string-name>
<surname>Crabb</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Heath</surname>
<given-names>WR</given-names>
</string-name> (<year>2011</year>) <article-title>Blood&#8208;stage <italic>Plasmodium berghei</italic> infection generates a potent, specific CD8+ T&#8208;Cell response despite residence largely in cells lacking MHC I processing machinery</article-title>. <source>J Infect Dis</source>
<volume>204</volume>: <fpage>1989</fpage>&#8211;<lpage>1996</lpage>
<pub-id pub-id-type="pmid">21998471</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0046"><mixed-citation publication-type="journal" id="emmm201708123-cit-0046">
<string-name>
<surname>Lau</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Fernandez&#8208;Ruiz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Mollard</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Sturm</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Neller</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Cozijnsen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Gregory</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Davey</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Jones</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Lin</surname>
<given-names>YH</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2014</year>) <article-title>CD8<sup>+</sup> T cells from a Novel T cell receptor transgenic mouse induce liver&#8208;stage immunity that can be boosted by blood&#8208;stage infection in rodent malaria</article-title>. <source>PLoS Pathog</source>
<volume>10</volume>: <fpage>e1004135</fpage>
<pub-id pub-id-type="pmid">24854165</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0047"><mixed-citation publication-type="journal" id="emmm201708123-cit-0047">
<string-name>
<surname>Liu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Cao</surname>
<given-names>X</given-names>
</string-name> (<year>2015</year>) <article-title>Regulatory dendritic cells in autoimmunity: a comprehensive review</article-title>. <source>J Autoimmun</source>
<volume>63</volume>: <fpage>1</fpage>&#8211;<lpage>12</lpage>
<pub-id pub-id-type="pmid">26255250</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0048"><mixed-citation publication-type="journal" id="emmm201708123-cit-0048">
<string-name>
<surname>Lonnberg</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Svensson</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Fernandez&#8208;Ruiz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Sebina</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Montandon</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Soon</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Fogg</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Nair</surname>
<given-names>AS</given-names>
</string-name>, <string-name>
<surname>Liligeto</surname>
<given-names>U</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2017</year>) <article-title>Single&#8208;cell RNA&#8208;seq and computational analysis using temporal mixture modelling resolves Th1/Tfh fate bifurcation in malaria</article-title>. <source>Sci Immunol</source>
<volume>2</volume>: <fpage>eaal2192</fpage>
<pub-id pub-id-type="pmid">28345074</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0049"><mixed-citation publication-type="journal" id="emmm201708123-cit-0049">
<string-name>
<surname>Lundie</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>de Koning&#8208;Ward</surname>
<given-names>TF</given-names>
</string-name>, <string-name>
<surname>Davey</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Nie</surname>
<given-names>CQ</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Lau</surname>
<given-names>LS</given-names>
</string-name>, <string-name>
<surname>Mintern</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Belz</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Schofield</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Carbone</surname>
<given-names>FR</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2008</year>) <article-title>Blood&#8208;stage Plasmodium infection induces CD8+ T lymphocytes to parasite&#8208;expressed antigens, largely regulated by CD8alpha+ dendritic cells</article-title>. <source>PNAS</source>
<volume>105</volume>: <fpage>14509</fpage>&#8211;<lpage>14514</lpage>
<pub-id pub-id-type="pmid">18799734</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0050"><mixed-citation publication-type="journal" id="emmm201708123-cit-0050">
<string-name>
<surname>Lundie</surname>
<given-names>RJ</given-names>
</string-name>, <string-name>
<surname>Young</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Davey</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Villadangos</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Carbone</surname>
<given-names>FR</given-names>
</string-name>, <string-name>
<surname>Heath</surname>
<given-names>WR</given-names>
</string-name>, <string-name>
<surname>Crabb</surname>
<given-names>BS</given-names>
</string-name> (<year>2010</year>) <article-title>Blood&#8208;stage <italic>Plasmodium berghei</italic> infection leads to short&#8208;lived parasite&#8208;associated antigen presentation by dendritic cells</article-title>. <source>Eur J Immunol</source>
<volume>40</volume>: <fpage>1674</fpage>&#8211;<lpage>1681</lpage>
<pub-id pub-id-type="pmid">20391433</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0051"><mixed-citation publication-type="journal" id="emmm201708123-cit-0051">
<string-name>
<surname>Manzoni</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Briquet</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Risco&#8208;Castillo</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Gaultier</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Topcu</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Ivanescu</surname>
<given-names>ML</given-names>
</string-name>, <string-name>
<surname>Franetich</surname>
<given-names>JF</given-names>
</string-name>, <string-name>
<surname>Hoareau&#8208;Coudert</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Mazier</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Silvie</surname>
<given-names>O</given-names>
</string-name> (<year>2014</year>) <article-title>A rapid and robust selection procedure for generating drug&#8208;selectable marker&#8208;free recombinant malaria parasites</article-title>. <source>Sci Rep</source>
<volume>4</volume>: <fpage>4760</fpage>
<pub-id pub-id-type="pmid">24755823</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0052"><mixed-citation publication-type="journal" id="emmm201708123-cit-0052">
<string-name>
<surname>Martinez&#8208;Lopez</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Iborra</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Conde&#8208;Garrosa</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Sancho</surname>
<given-names>D</given-names>
</string-name> (<year>2015</year>) <article-title>Batf3&#8208;dependent CD103<sup>+</sup> dendritic cells are major producers of IL&#8208;12 that drive local Th1 immunity against Leishmania major infection in mice</article-title>. <source>Eur J Immunol</source>
<volume>45</volume>: <fpage>119</fpage>&#8211;<lpage>129</lpage>
<pub-id pub-id-type="pmid">25312824</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0053"><mixed-citation publication-type="journal" id="emmm201708123-cit-0053">
<string-name>
<surname>Mashayekhi</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Sandau</surname>
<given-names>MM</given-names>
</string-name>, <string-name>
<surname>Dunay</surname>
<given-names>IR</given-names>
</string-name>, <string-name>
<surname>Frickel</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Goldszmid</surname>
<given-names>RS</given-names>
</string-name>, <string-name>
<surname>Sher</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ploegh</surname>
<given-names>HL</given-names>
</string-name>, <string-name>
<surname>Murphy</surname>
<given-names>TL</given-names>
</string-name>, <string-name>
<surname>Sibley</surname>
<given-names>LD</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2011</year>) <article-title>CD8alpha(+) dendritic cells are the critical source of interleukin&#8208;12 that controls acute infection by <italic>Toxoplasma gondii</italic> tachyzoites</article-title>. <source>Immunity</source>
<volume>35</volume>: <fpage>249</fpage>&#8211;<lpage>259</lpage>
<pub-id pub-id-type="pmid">21867928</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0054"><mixed-citation publication-type="journal" id="emmm201708123-cit-0054">
<string-name>
<surname>Nacer</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Movila</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sohet</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Girgis</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Gundra</surname>
<given-names>UM</given-names>
</string-name>, <string-name>
<surname>Loke</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Daneman</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Frevert</surname>
<given-names>U</given-names>
</string-name> (<year>2014</year>) <article-title>Experimental cerebral malaria pathogenesis&#8208;hemodynamics at the blood brain barrier</article-title>. <source>PLoS Pathog</source>
<volume>10</volume>: <fpage>e1004528</fpage>
<pub-id pub-id-type="pmid">25474413</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0055"><mixed-citation publication-type="journal" id="emmm201708123-cit-0055">
<string-name>
<surname>Natarajan</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>Stern</surname>
<given-names>LJ</given-names>
</string-name>, <string-name>
<surname>Sadegh&#8208;Nasseri</surname>
<given-names>S</given-names>
</string-name> (<year>1999</year>) <article-title>Sodium dodecyl sulfate stability of HLA&#8208;DR1 complexes correlates with burial of hydrophobic residues in pocket 1</article-title>. <source>J Immunol</source>
<volume>162</volume>: <fpage>3463</fpage>&#8211;<lpage>3470</lpage>
<pub-id pub-id-type="pmid">10092802</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0056"><mixed-citation publication-type="journal" id="emmm201708123-cit-0056">
<string-name>
<surname>Oakley</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Sahu</surname>
<given-names>BR</given-names>
</string-name>, <string-name>
<surname>Lotspeich&#8208;Cole</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Solanki</surname>
<given-names>NR</given-names>
</string-name>, <string-name>
<surname>Majam</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Pham</surname>
<given-names>PT</given-names>
</string-name>, <string-name>
<surname>Banerjee</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Kozakai</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Derrick</surname>
<given-names>SC</given-names>
</string-name>, <string-name>
<surname>Kumar</surname>
<given-names>S</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2013</year>) <article-title>The transcription factor T&#8208;bet regulates parasitemia and promotes pathogenesis during <italic>Plasmodium berghei</italic> ANKA Murine Malaria</article-title>. <source>J Immunol</source>
<volume>191</volume>: <fpage>4699</fpage>&#8211;<lpage>4708</lpage>
<pub-id pub-id-type="pmid">24078698</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0057"><mixed-citation publication-type="journal" id="emmm201708123-cit-0057">
<string-name>
<surname>Olotu</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Fegan</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Wambua</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Nyangweso</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Leach</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Lievens</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Kaslow</surname>
<given-names>DC</given-names>
</string-name>, <string-name>
<surname>Njuguna</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Marsh</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Bejon</surname>
<given-names>P</given-names>
</string-name> (<year>2016</year>) <article-title>Seven&#8208;Year efficacy of RTS, S/AS01 malaria vaccine among young African children</article-title>. <source>N Engl J Med</source>
<volume>374</volume>: <fpage>2519</fpage>&#8211;<lpage>2529</lpage>
<pub-id pub-id-type="pmid">27355532</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0058"><mixed-citation publication-type="journal" id="emmm201708123-cit-0058">
<string-name>
<surname>Otto</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Bohme</surname>
<given-names>U</given-names>
</string-name>, <string-name>
<surname>Jackson</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>Hunt</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Franke&#8208;Fayard</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Hoeijmakers</surname>
<given-names>WA</given-names>
</string-name>, <string-name>
<surname>Religa</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Robertson</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Sanders</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ogun</surname>
<given-names>SA</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2014</year>) <article-title>A comprehensive evaluation of rodent malaria parasite genomes and gene expression</article-title>. <source>BMC Biol</source>
<volume>12</volume>: <fpage>86</fpage>
<pub-id pub-id-type="pmid">25359557</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0059"><mixed-citation publication-type="journal" id="emmm201708123-cit-0059">
<string-name>
<surname>Pasini</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Braks</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Fonager</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Klop</surname>
<given-names>O</given-names>
</string-name>, <string-name>
<surname>Aime</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Spaccapelo</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Otto</surname>
<given-names>TD</given-names>
</string-name>, <string-name>
<surname>Berriman</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hiss</surname>
<given-names>JA</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>AW</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2013</year>) <article-title>Proteomic and genetic analyses demonstrate that <italic>Plasmodium berghei</italic> blood stages export a large and diverse repertoire of proteins</article-title>. <source>Mol Cell Proteomics</source>
<volume>12</volume>: <fpage>426</fpage>&#8211;<lpage>448</lpage>
<pub-id pub-id-type="pmid">23197789</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0060"><mixed-citation publication-type="journal" id="emmm201708123-cit-0060">
<string-name>
<surname>Perez&#8208;Casal</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Potter</surname>
<given-names>AA</given-names>
</string-name> (<year>2016</year>) <article-title>Glyceradehyde&#8208;3&#8208;phosphate dehydrogenase as a suitable vaccine candidate for protection against bacterial and parasitic diseases</article-title>. <source>Vaccine</source>
<volume>34</volume>: <fpage>1012</fpage>&#8211;<lpage>1017</lpage>
<pub-id pub-id-type="pmid">26686572</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0061"><mixed-citation publication-type="journal" id="emmm201708123-cit-0061">
<string-name>
<surname>Perez&#8208;Mazliah</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Ng</surname>
<given-names>DH</given-names>
</string-name>, <string-name>
<surname>Freitas do Rosario</surname>
<given-names>AP</given-names>
</string-name>, <string-name>
<surname>McLaughlin</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Mastelic&#8208;Gavillet</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Sodenkamp</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Kushinga</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Langhorne</surname>
<given-names>J</given-names>
</string-name> (<year>2015</year>) <article-title>Disruption of IL&#8208;21 signaling affects T cell&#8208;B cell interactions and abrogates protective humoral immunity to malaria</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>: <fpage>e1004715</fpage>
<pub-id pub-id-type="pmid">25763578</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0062"><mixed-citation publication-type="journal" id="emmm201708123-cit-0062">
<string-name>
<surname>Piva</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Tetlak</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Claser</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Karjalainen</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Ruedl</surname>
<given-names>C</given-names>
</string-name> (<year>2012</year>) <article-title>Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria</article-title>. <source>J Immunol</source>
<volume>189</volume>: <fpage>1128</fpage>&#8211;<lpage>1132</lpage>
<pub-id pub-id-type="pmid">22732587</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0063"><mixed-citation publication-type="journal" id="emmm201708123-cit-0063">
<string-name>
<surname>Poh</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>Howland</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Grotenbreg</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name> (<year>2014</year>) <article-title>Damage to the blood&#8208;brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificities</article-title>. <source>Infect Immun</source>
<volume>82</volume>: <fpage>4854</fpage>&#8211;<lpage>4864</lpage>
<pub-id pub-id-type="pmid">25156726</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0064"><mixed-citation publication-type="journal" id="emmm201708123-cit-0064">
<string-name>
<surname>Pozsgay</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Szekanecz</surname>
<given-names>Z</given-names>
</string-name>, <string-name>
<surname>Sarmay</surname>
<given-names>G</given-names>
</string-name> (<year>2017</year>) <article-title>Antigen&#8208;specific immunotherapies in rheumatic diseases</article-title>. <source>Nat Rev Rheumatol</source>
<volume>13</volume>: <fpage>525</fpage>&#8211;<lpage>537</lpage>
<pub-id pub-id-type="pmid">28701761</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0065"><mixed-citation publication-type="journal" id="emmm201708123-cit-0065">
<string-name>
<surname>Price</surname>
<given-names>JD</given-names>
</string-name>, <string-name>
<surname>Hotta&#8208;Iwamura</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Beauchamp</surname>
<given-names>NM</given-names>
</string-name>, <string-name>
<surname>Tarbell</surname>
<given-names>KV</given-names>
</string-name> (<year>2015</year>) <article-title>DCIR2<sup>+</sup> cDC2 DCs and Zbtb32 restore CD4<sup>+</sup> T&#8208;cell tolerance and inhibit diabetes</article-title>. <source>Diabetes</source>
<volume>64</volume>: <fpage>3521</fpage>&#8211;<lpage>3531</lpage>
<pub-id pub-id-type="pmid">26070317</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0066"><mixed-citation publication-type="journal" id="emmm201708123-cit-0066">
<string-name>
<surname>Radtke</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Kastenmuller</surname>
<given-names>W</given-names>
</string-name>, <string-name>
<surname>Espinosa</surname>
<given-names>DA</given-names>
</string-name>, <string-name>
<surname>Gerner</surname>
<given-names>MY</given-names>
</string-name>, <string-name>
<surname>Tse</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Sinnis</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Germain</surname>
<given-names>RN</given-names>
</string-name>, <string-name>
<surname>Zavala</surname>
<given-names>FP</given-names>
</string-name>, <string-name>
<surname>Cockburn</surname>
<given-names>IA</given-names>
</string-name> (<year>2015a</year>) <article-title>Lymph&#8208;node resident CD8alpha+ dendritic cells capture antigens from migratory malaria sporozoites and induce CD8<sup>+</sup> T cell responses</article-title>. <source>PLoS Pathog</source>
<volume>11</volume>: <fpage>e1004637</fpage>
<pub-id pub-id-type="pmid">25658939</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0067"><mixed-citation publication-type="journal" id="emmm201708123-cit-0067">
<string-name>
<surname>Radtke</surname>
<given-names>AJ</given-names>
</string-name>, <string-name>
<surname>Tse</surname>
<given-names>SW</given-names>
</string-name>, <string-name>
<surname>Zavala</surname>
<given-names>F</given-names>
</string-name> (<year>2015b</year>) <article-title>From the draining lymph node to the liver: the induction and effector mechanisms of malaria&#8208;specific CD8+ T cells</article-title>. <source>Semin Immunopathol</source>
<volume>37</volume>: <fpage>211</fpage>&#8211;<lpage>220</lpage>
<pub-id pub-id-type="pmid">25917387</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0068"><mixed-citation publication-type="journal" id="emmm201708123-cit-0068">
<string-name>
<surname>Renia</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Goh</surname>
<given-names>YS</given-names>
</string-name> (<year>2016</year>) <article-title>Malaria parasites: the great escape</article-title>. <source>Front Immunol</source>
<volume>7</volume>: <fpage>463</fpage>
<pub-id pub-id-type="pmid">27872623</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0069"><mixed-citation publication-type="journal" id="emmm201708123-cit-0069">
<string-name>
<surname>Riquelme</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Pogu</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Anegon</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Bueno</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Kalergis</surname>
<given-names>AM</given-names>
</string-name> (<year>2015</year>) <article-title>Carbon monoxide impairs mitochondria&#8208;dependent endosomal maturation and antigen presentation in dendritic cells</article-title>. <source>Eur J Immunol</source>
<volume>45</volume>: <fpage>3269</fpage>&#8211;<lpage>3288</lpage>
<pub-id pub-id-type="pmid">26461179</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0070"><mixed-citation publication-type="journal" id="emmm201708123-cit-0070">
<string-name>
<surname>Safeukui</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gomez</surname>
<given-names>ND</given-names>
</string-name>, <string-name>
<surname>Adelani</surname>
<given-names>AA</given-names>
</string-name>, <string-name>
<surname>Burte</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Afolabi</surname>
<given-names>NK</given-names>
</string-name>, <string-name>
<surname>Akondy</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Velazquez</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Holder</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Tewari</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Buffet</surname>
<given-names>P</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2015</year>) <article-title>Malaria induces anemia through CD8<sup>+</sup> T cell&#8208;dependent parasite clearance and erythrocyte removal in the spleen</article-title>. <source>MBio</source>
<volume>6</volume>: <fpage>e02493&#8208;14</fpage>
<pub-id pub-id-type="pmid">25604792</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0071"><mixed-citation publication-type="journal" id="emmm201708123-cit-0071">
<string-name>
<surname>Sahara</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Shastri</surname>
<given-names>N</given-names>
</string-name> (<year>2003</year>) <article-title>Second class minors: molecular identification of the autosomal H46 histocompatibility locus as a peptide presented by major histocompatibility complex class II molecules</article-title>. <source>J Exp Med</source>
<volume>197</volume>: <fpage>375</fpage>&#8211;<lpage>385</lpage>
<pub-id pub-id-type="pmid">12566421</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0072"><mixed-citation publication-type="journal" id="emmm201708123-cit-0072">
<string-name>
<surname>Schnorrer</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Behrens</surname>
<given-names>GM</given-names>
</string-name>, <string-name>
<surname>Wilson</surname>
<given-names>NS</given-names>
</string-name>, <string-name>
<surname>Pooley</surname>
<given-names>JL</given-names>
</string-name>, <string-name>
<surname>Smith</surname>
<given-names>CM</given-names>
</string-name>, <string-name>
<surname>El&#8208;Sukkari</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Davey</surname>
<given-names>G</given-names>
</string-name>, <string-name>
<surname>Kupresanin</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Li</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Maraskovsky</surname>
<given-names>E</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2006</year>) <article-title>The dominant role of CD8<sup>+</sup> dendritic cells in cross&#8208;presentation is not dictated by antigen capture</article-title>. <source>Proc Natl Acad Sci USA</source>
<volume>103</volume>: <fpage>10729</fpage>&#8211;<lpage>10734</lpage>
<pub-id pub-id-type="pmid">16807294</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0073"><mixed-citation publication-type="journal" id="emmm201708123-cit-0073">
<string-name>
<surname>Scholzen</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Sauerwein</surname>
<given-names>RW</given-names>
</string-name> (<year>2016</year>) <article-title>Immune activation and induction of memory: lessons learned from controlled human malaria infection with Plasmodium falciparum</article-title>. <source>Parasitology</source>
<volume>143</volume>: <fpage>224</fpage>&#8211;<lpage>235</lpage>
<pub-id pub-id-type="pmid">26864135</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0074"><mixed-citation publication-type="journal" id="emmm201708123-cit-0074">
<string-name>
<surname>Sebina</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>James</surname>
<given-names>KR</given-names>
</string-name>, <string-name>
<surname>Soon</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Fogg</surname>
<given-names>LG</given-names>
</string-name>, <string-name>
<surname>Best</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Labastida Rivera</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Montes de Oca</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Amante</surname>
<given-names>FH</given-names>
</string-name>, <string-name>
<surname>Thomas</surname>
<given-names>BS</given-names>
</string-name>, <string-name>
<surname>Beattie</surname>
<given-names>L</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2016</year>) <article-title>IFNAR1&#8208;Signalling Obstructs ICOS&#8208;mediated Humoral Immunity during Non&#8208;lethal Blood&#8208;Stage Plasmodium Infection</article-title>. <source>PLoS Pathog</source>
<volume>12</volume>: <fpage>e1005999</fpage>
<pub-id pub-id-type="pmid">27812214</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0075"><mixed-citation publication-type="journal" id="emmm201708123-cit-0075">
<string-name>
<surname>Sidney</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Southwood</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Moore</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Oseroff</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Pinilla</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Grey</surname>
<given-names>HM</given-names>
</string-name>, <string-name>
<surname>Sette</surname>
<given-names>A</given-names>
</string-name> (<year>2013</year>) <article-title>Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture</article-title>. <source>Curr Protoc Immunol</source>
<volume>Chapter 18</volume>: <fpage>Unit 18 13</fpage>
</mixed-citation></ref><ref id="emmm201708123-bib-0076"><mixed-citation publication-type="journal" id="emmm201708123-cit-0076">
<string-name>
<surname>Sissoko</surname>
<given-names>MS</given-names>
</string-name>, <string-name>
<surname>Healy</surname>
<given-names>SA</given-names>
</string-name>, <string-name>
<surname>Katile</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Omaswa</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Zaidi</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Gabriel</surname>
<given-names>EE</given-names>
</string-name>, <string-name>
<surname>Kamate</surname>
<given-names>B</given-names>
</string-name>, <string-name>
<surname>Samake</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Guindo</surname>
<given-names>MA</given-names>
</string-name>, <string-name>
<surname>Dolo</surname>
<given-names>A</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2017</year>) <article-title>Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria&#8208;exposed adults in Mali: a randomised, double&#8208;blind phase 1 trial</article-title>. <source>Lancet Infect Dis</source>
<volume>17</volume>: <fpage>498</fpage>&#8211;<lpage>509</lpage>
<pub-id pub-id-type="pmid">28216244</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0077"><mixed-citation publication-type="journal" id="emmm201708123-cit-0077">
<string-name>
<surname>Sofron</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Ritz</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Neri</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Fugmann</surname>
<given-names>T</given-names>
</string-name> (<year>2016</year>) <article-title>High&#8208;resolution analysis of the murine MHC class II immunopeptidome</article-title>. <source>Eur J Immunol</source>
<volume>46</volume>: <fpage>319</fpage>&#8211;<lpage>328</lpage>
<pub-id pub-id-type="pmid">26495903</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0078"><mixed-citation publication-type="journal" id="emmm201708123-cit-0078">
<string-name>
<surname>de Souza</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Hafalla</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>EM</given-names>
</string-name>, <string-name>
<surname>Couper</surname>
<given-names>KN</given-names>
</string-name> (<year>2010</year>) <article-title>Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease</article-title>. <source>Parasitology</source>
<volume>137</volume>: <fpage>755</fpage>&#8211;<lpage>772</lpage>
<pub-id pub-id-type="pmid">20028608</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0079"><mixed-citation publication-type="journal" id="emmm201708123-cit-0079">
<string-name>
<surname>Spielmann</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Fergusen</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Beck</surname>
<given-names>HP</given-names>
</string-name> (<year>2003</year>) <article-title>etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite&#8208;host cell interface</article-title>. <source>Mol Biol Cell</source>
<volume>14</volume>: <fpage>1529</fpage>&#8211;<lpage>1544</lpage>
<pub-id pub-id-type="pmid">12686607</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0080"><mixed-citation publication-type="journal" id="emmm201708123-cit-0080">
<string-name>
<surname>Sponaas</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Cadman</surname>
<given-names>ET</given-names>
</string-name>, <string-name>
<surname>Voisine</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Harrison</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Boonstra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>O'Garra</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Langhorne</surname>
<given-names>J</given-names>
</string-name> (<year>2006</year>) <article-title>Malaria infection changes the ability of splenic dendritic cell populations to stimulate antigen&#8208;specific T cells</article-title>. <source>J Exp Med</source>
<volume>203</volume>: <fpage>1427</fpage>&#8211;<lpage>1433</lpage>
<pub-id pub-id-type="pmid">16754719</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0081"><mixed-citation publication-type="journal" id="emmm201708123-cit-0081">
<string-name>
<surname>Stephens</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Langhorne</surname>
<given-names>J</given-names>
</string-name> (<year>2010</year>) <article-title>Effector memory Th1 CD4 T cells are maintained in a mouse model of chronic malaria</article-title>. <source>PLoS Pathog</source>
<volume>6</volume>: <fpage>e1001208</fpage>
<pub-id pub-id-type="pmid">21124875</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0082"><mixed-citation publication-type="journal" id="emmm201708123-cit-0082">
<string-name>
<surname>Swanson</surname>
<given-names>PA</given-names>
<suffix>II</suffix>
</string-name>, <string-name>
<surname>Hart</surname>
<given-names>GT</given-names>
</string-name>, <string-name>
<surname>Russo</surname>
<given-names>MV</given-names>
</string-name>, <string-name>
<surname>Nayak</surname>
<given-names>D</given-names>
</string-name>, <string-name>
<surname>Yazew</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Pena</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Khan</surname>
<given-names>SM</given-names>
</string-name>, <string-name>
<surname>Janse</surname>
<given-names>CJ</given-names>
</string-name>, <string-name>
<surname>Pierce</surname>
<given-names>SK</given-names>
</string-name>, <string-name>
<surname>McGavern</surname>
<given-names>DB</given-names>
</string-name> (<year>2016</year>) <article-title>CD8<sup>+</sup> T cells induce fatal brainstem pathology during cerebral malaria via luminal antigen&#8208;specific engagement of brain vasculature</article-title>. <source>PLoS Pathog</source>
<volume>12</volume>: <fpage>e1006022</fpage>
<pub-id pub-id-type="pmid">27907215</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0083"><mixed-citation publication-type="journal" id="emmm201708123-cit-0083">
<string-name>
<surname>Swearingen</surname>
<given-names>KE</given-names>
</string-name>, <string-name>
<surname>Lindner</surname>
<given-names>SE</given-names>
</string-name>, <string-name>
<surname>Shi</surname>
<given-names>L</given-names>
</string-name>, <string-name>
<surname>Shears</surname>
<given-names>MJ</given-names>
</string-name>, <string-name>
<surname>Harupa</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Hopp</surname>
<given-names>CS</given-names>
</string-name>, <string-name>
<surname>Vaughan</surname>
<given-names>AM</given-names>
</string-name>, <string-name>
<surname>Springer</surname>
<given-names>TA</given-names>
</string-name>, <string-name>
<surname>Moritz</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Kappe</surname>
<given-names>SH</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2016</year>) <article-title>Interrogating the plasmodium sporozoite surface: identification of surface&#8208;exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry&#8208;based proteomics</article-title>. <source>PLoS Pathog</source>
<volume>12</volume>: <fpage>e1005606</fpage>
<pub-id pub-id-type="pmid">27128092</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0084"><mixed-citation publication-type="journal" id="emmm201708123-cit-0084">
<string-name>
<surname>Tham</surname>
<given-names>WH</given-names>
</string-name>, <string-name>
<surname>Beeson</surname>
<given-names>JG</given-names>
</string-name>, <string-name>
<surname>Rayner</surname>
<given-names>JC</given-names>
</string-name> (<year>2017</year>) <article-title>Plasmodium vivax vaccine research &#8211; we've only just begun</article-title>. <source>Int J Parasitol</source>
<volume>47</volume>: <fpage>111</fpage>&#8211;<lpage>118</lpage>
<pub-id pub-id-type="pmid">27899329</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0085"><mixed-citation publication-type="journal" id="emmm201708123-cit-0085">
<string-name>
<surname>Van Braeckel&#8208;Budimir</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Kurup</surname>
<given-names>SP</given-names>
</string-name>, <string-name>
<surname>Harty</surname>
<given-names>JT</given-names>
</string-name> (<year>2016</year>) <article-title>Regulatory issues in immunity to liver and blood&#8208;stage malaria</article-title>. <source>Curr Opin Immunol</source>
<volume>42</volume>: <fpage>91</fpage>&#8211;<lpage>97</lpage>
<pub-id pub-id-type="pmid">27351448</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0086"><mixed-citation publication-type="journal" id="emmm201708123-cit-0086">
<string-name>
<surname>Van den Steen</surname>
<given-names>PE</given-names>
</string-name>, <string-name>
<surname>Deroost</surname>
<given-names>K</given-names>
</string-name>, <string-name>
<surname>Van Aelst</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Geurts</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Martens</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Struyf</surname>
<given-names>S</given-names>
</string-name>, <string-name>
<surname>Nie</surname>
<given-names>CQ</given-names>
</string-name>, <string-name>
<surname>Hansen</surname>
<given-names>DS</given-names>
</string-name>, <string-name>
<surname>Matthys</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Van Damme</surname>
<given-names>J</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2008</year>) <article-title>CXCR3 determines strain susceptibility to murine cerebral malaria by mediating T lymphocyte migration toward IFN&#8208;gamma&#8208;induced chemokines</article-title>. <source>Eur J Immunol</source>
<volume>38</volume>: <fpage>1082</fpage>&#8211;<lpage>1095</lpage>
<pub-id pub-id-type="pmid">18383042</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0087"><mixed-citation publication-type="journal" id="emmm201708123-cit-0087">
<string-name>
<surname>Villegas&#8208;Mendez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Greig</surname>
<given-names>R</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>de Souza</surname>
<given-names>JB</given-names>
</string-name>, <string-name>
<surname>Gwyer Findlay</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Stumhofer</surname>
<given-names>JS</given-names>
</string-name>, <string-name>
<surname>Hafalla</surname>
<given-names>JC</given-names>
</string-name>, <string-name>
<surname>Blount</surname>
<given-names>DG</given-names>
</string-name>, <string-name>
<surname>Hunter</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Riley</surname>
<given-names>EM</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2012</year>) <article-title>IFN&#8208;gamma&#8208;producing CD4<sup>+</sup> T cells promote experimental cerebral malaria by modulating CD8<sup>+</sup> T cell accumulation within the brain</article-title>. <source>J Immunol</source>
<volume>189</volume>: <fpage>968</fpage>&#8211;<lpage>979</lpage>
<pub-id pub-id-type="pmid">22723523</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0088"><mixed-citation publication-type="journal" id="emmm201708123-cit-0088">
<string-name>
<surname>Villegas&#8208;Mendez</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Inkson</surname>
<given-names>CA</given-names>
</string-name>, <string-name>
<surname>Shaw</surname>
<given-names>TN</given-names>
</string-name>, <string-name>
<surname>Strangward</surname>
<given-names>P</given-names>
</string-name>, <string-name>
<surname>Couper</surname>
<given-names>KN</given-names>
</string-name> (<year>2016</year>) <article-title>Long&#8208;lived CD4+IFN&#8208;gamma+ T cells rather than short&#8208;lived CD4+IFN&#8208;gamma+IL&#8208;10+ T cells initiate rapid IL&#8208;10 production to suppress anamnestic T cell responses during secondary malaria infection</article-title>. <source>J Immunol</source>
<volume>197</volume>: <fpage>3152</fpage>&#8211;<lpage>3164</lpage>
<pub-id pub-id-type="pmid">27630165</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0089"><mixed-citation publication-type="journal" id="emmm201708123-cit-0089">
<string-name>
<surname>Vu Manh</surname>
<given-names>TP</given-names>
</string-name>, <string-name>
<surname>Bertho</surname>
<given-names>N</given-names>
</string-name>, <string-name>
<surname>Hosmalin</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Schwartz&#8208;Cornil</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Dalod</surname>
<given-names>M</given-names>
</string-name> (<year>2015</year>) <article-title>Investigating evolutionary conservation of dendritic cell subset identity and functions</article-title>. <source>Front Immunol</source>
<volume>6</volume>: <fpage>260</fpage>
<pub-id pub-id-type="pmid">26082777</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0090"><mixed-citation publication-type="journal" id="emmm201708123-cit-0090">
<string-name>
<surname>Yamazaki</surname>
<given-names>C</given-names>
</string-name>, <string-name>
<surname>Sugiyama</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Ohta</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Hemmi</surname>
<given-names>H</given-names>
</string-name>, <string-name>
<surname>Hamada</surname>
<given-names>E</given-names>
</string-name>, <string-name>
<surname>Sasaki</surname>
<given-names>I</given-names>
</string-name>, <string-name>
<surname>Fukuda</surname>
<given-names>Y</given-names>
</string-name>, <string-name>
<surname>Yano</surname>
<given-names>T</given-names>
</string-name>, <string-name>
<surname>Nobuoka</surname>
<given-names>M</given-names>
</string-name>, <string-name>
<surname>Hirashima</surname>
<given-names>T</given-names>
</string-name>
<italic>et&#160;al</italic> (<year>2013</year>) <article-title>Critical roles of a dendritic cell subset expressing a chemokine receptor, XCR1</article-title>. <source>J Immunol</source>
<volume>190</volume>: <fpage>6071</fpage>&#8211;<lpage>6082</lpage>
<pub-id pub-id-type="pmid">23670193</pub-id></mixed-citation></ref><ref id="emmm201708123-bib-0091"><mixed-citation publication-type="journal" id="emmm201708123-cit-0091">
<string-name>
<surname>Zander</surname>
<given-names>RA</given-names>
</string-name>, <string-name>
<surname>Guthmiller</surname>
<given-names>JJ</given-names>
</string-name>, <string-name>
<surname>Graham</surname>
<given-names>AC</given-names>
</string-name>, <string-name>
<surname>Pope</surname>
<given-names>RL</given-names>
</string-name>, <string-name>
<surname>Burke</surname>
<given-names>BE</given-names>
</string-name>, <string-name>
<surname>Carr</surname>
<given-names>DJ</given-names>
</string-name>, <string-name>
<surname>Butler</surname>
<given-names>NS</given-names>
</string-name> (<year>2016</year>) <article-title>Type I interferons induce T regulatory 1 responses and restrict humoral immunity during experimental malaria</article-title>. <source>PLoS Pathog</source>
<volume>12</volume>: <fpage>e1005945</fpage>
<pub-id pub-id-type="pmid">27732671</pub-id></mixed-citation></ref></ref-list></back></article>